The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO.
The techniques used to select and/or place only one embryo from FERTILIZATION IN VITRO into the uterine cavity to establish a singleton pregnancy.
An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.
The ratio of the number of conceptions (CONCEPTION) including LIVE BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.
Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS.
Preservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens.
The condition of carrying two or more FETUSES simultaneously.
An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility (INFERTILITY, MALE).
Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.
A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper.
The event that a FETUS is born alive with heartbeats or RESPIRATION regardless of GESTATIONAL AGE. Such liveborn is called a newborn infant (INFANT, NEWBORN).
Inability to reproduce after a specified period of unprotected intercourse. Reproductive sterility is permanent infertility.
Diminished or absent ability of a female to achieve conception.
The developmental entity of a fertilized egg (ZYGOTE) in animal species other than MAMMALS. For chickens, use CHICK EMBRYO.
Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.
The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching.
The earliest developmental stage of a fertilized ovum (ZYGOTE) during which there are several mitotic divisions within the ZONA PELLUCIDA. Each cleavage or segmentation yields two BLASTOMERES of about half size of the parent cell. This cleavage stage generally covers the period up to 16-cell MORULA.
A technique in assisted reproduction (REPRODUCTIVE TECHNIQUES, ASSISTED) consisting of hormonal stimulation of the ovaries, follicular aspiration of preovulatory oocytes, in-vitro fertilization, and intrafallopian transfer of zygotes at the pronuclear stage (before cleavage).
Two individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic (TWINS, MONOZYGOTIC) or dizygotic (TWINS, DIZYGOTIC).
Transfer of preovulatory oocytes from donor to a suitable host. Oocytes are collected, fertilized in vitro, and transferred to a host that can be human or animal.
Clinical and laboratory techniques used to enhance fertility in humans and animals.
Methods pertaining to the generation of new individuals, including techniques used in selective BREEDING, cloning (CLONING, ORGANISM), and assisted reproduction (REPRODUCTIVE TECHNIQUES, ASSISTED).
Morphological and physiological development of EMBRYOS.
Morphological and physiological development of EMBRYOS or FETUSES.
Undifferentiated cells resulting from cleavage of a fertilized egg (ZYGOTE). Inside the intact ZONA PELLUCIDA, each cleavage yields two blastomeres of about half size of the parent cell. Up to the 8-cell stage, all of the blastomeres are totipotent. The 16-cell MORULA contains outer cells and inner cells.
Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.
Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM).
A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN).
The technique of maintaining or growing mammalian EMBRYOS in vitro. This method offers an opportunity to observe EMBRYONIC DEVELOPMENT; METABOLISM; and susceptibility to TERATOGENS.
The number of births in a given population per year or other unit of time.
Determination of the nature of a pathological condition or disease in the OVUM; ZYGOTE; or BLASTOCYST prior to implantation. CYTOGENETIC ANALYSIS is performed to determine the presence or absence of genetic disease.
An early embryo that is a compact mass of about 16 BLASTOMERES. It resembles a cluster of mulberries with two types of cells, outer cells and inner cells. Morula is the stage before BLASTULA in non-mammalian animals or a BLASTOCYST in mammals.
The introduction of functional (usually cloned) GENES into cells. A variety of techniques and naturally occurring processes are used for the gene transfer such as cell hybridization, LIPOSOMES or microcell-mediated gene transfer, ELECTROPORATION, chromosome-mediated gene transfer, TRANSFECTION, and GENETIC TRANSDUCTION. Gene transfer may result in genetically transformed cells and individual organisms.
A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.
The transformation of a liquid to a glassy solid i.e., without the formation of crystals during the cooling process.
Early pregnancy loss during the EMBRYO, MAMMALIAN stage of development. In the human, this period comprises the second through eighth week after fertilization.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
The formation of one or more genetically identical organisms derived by vegetative reproduction from a single cell. The source nuclear material can be embryo-derived, fetus-derived, or taken from an adult somatic cell.
Diseases involving the FALLOPIAN TUBES including neoplasms (FALLOPIAN TUBE NEOPLASMS); SALPINGITIS; tubo-ovarian abscess; and blockage.
Procedures to obtain viable OOCYTES from the host. Oocytes most often are collected by needle aspiration from OVARIAN FOLLICLES before OVULATION.
A potentially life-threatening condition in which EMBRYO IMPLANTATION occurs outside the cavity of the UTERUS. Most ectopic pregnancies (>96%) occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity (PREGNANCY, ABDOMINAL).
Occurrence or induction of release of more ova than are normally released at the same time in a given species. The term applies to both animals and humans.
Methods of implanting a CELL NUCLEUS from a donor cell into an enucleated acceptor cell.
The age of the mother in PREGNANCY.
Elements of limited time intervals, contributing to particular results or situations.
Artificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.
Selective abortion of one or more embryos or fetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or fetuses.
A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.
The fusion of a spermatozoon (SPERMATOZOA) with an OVUM thus resulting in the formation of a ZYGOTE.
A tough transparent membrane surrounding the OVUM. It is penetrated by the sperm during FERTILIZATION.
The naturally occurring transmission of genetic information between organisms, related or unrelated, circumventing parent-to-offspring transmission. Horizontal gene transfer may occur via a variety of naturally occurring processes such as GENETIC CONJUGATION; GENETIC TRANSDUCTION; and TRANSFECTION. It may result in a change of the recipient organism's genetic composition (TRANSFORMATION, GENETIC).
The condition of carrying TWINS simultaneously.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types.
The fertilized OVUM resulting from the fusion of a male and a female gamete.
The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.
The offspring in multiple pregnancies (PREGNANCY, MULTIPLE): TWINS; TRIPLETS; QUADRUPLETS; QUINTUPLETS; etc.
Liquids transforming into solids by the removal of heat.
The division of a ZYGOTE into two parts, each of which is capable of further development.
The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.
The most common (>96%) type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the FALLOPIAN TUBE, usually in the ampullary region where FERTILIZATION takes place.
Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
Women who allow themselves to be impregnated with the understanding that the offspring are to be given over to the parents who have commissioned the surrogate.
Insulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions.
Compounds which increase the capacity to conceive in females.
A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.
Three individuals derived from three FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.
The fluid surrounding the OVUM and GRANULOSA CELLS in the Graafian follicle (OVARIAN FOLLICLE). The follicular fluid contains sex steroids, glycoprotein hormones, plasma proteins, mucopolysaccharides, and enzymes.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes.
A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.
The performance of dissections, injections, surgery, etc., by the use of micromanipulators (attachments to a microscope) that manipulate tiny instruments.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.
Period from the onset of true OBSTETRIC LABOR to the complete dilatation of the CERVIX UTERI.
A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS.
The beta subunit of human CHORIONIC GONADOTROPIN. Its structure is similar to the beta subunit of LUTEINIZING HORMONE, except for the additional 30 amino acids at the carboxy end with the associated carbohydrate residues. HCG-beta is used as a diagnostic marker for early detection of pregnancy, spontaneous abortion (ABORTION, SPONTANEOUS); ECTOPIC PREGNANCY; HYDATIDIFORM MOLE; CHORIOCARCINOMA; or DOWN SYNDROME.
The number of offspring produced at one birth by a viviparous animal.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
Premature expulsion of the FETUS in animals.
Physiological mechanisms that sustain the state of PREGNANCY.
A technique that came into use in the mid-1980's for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes.
The potential of the FETUS to survive outside the UTERUS after birth, natural or induced. Fetal viability depends largely on the FETAL ORGAN MATURITY, and environmental conditions.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Contraction of the UTERINE MUSCLE.
Change in learning in one situation due to prior learning in another situation. The transfer can be positive (with second learning improved by first) or negative (where the reverse holds).
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Tests to determine whether or not an individual is pregnant.
Two off-spring from the same PREGNANCY. They are from a single fertilized OVUM that split into two EMBRYOS. Such twins are usually genetically identical and of the same sex.
The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility.
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
A major gonadotropin secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
The procedure of removing TISSUES, organs, or specimens from DONORS for reuse, such as TRANSPLANTATION.
The discharge of an OVUM from a rupturing follicle in the OVARY.
An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.
Utilization or disposal of an embryo that is fertilized but not immediately transplanted and resulting course of action.
Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
Inbred ICR mice are a strain of albino laboratory mice that have been selectively bred for consistent genetic makeup and high reproductive performance, making them widely used in biomedical research for studies involving reproduction, toxicology, pharmacology, and carcinogenesis.
A type of FLUORESCENCE SPECTROSCOPY using two FLUORESCENT DYES with overlapping emission and absorption spectra, which is used to indicate proximity of labeled molecules. This technique is useful for studying interactions of molecules and PROTEIN FOLDING.
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. They are used in embryological studies and to study the effects of certain chemicals on development.
The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization.
A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. (From Dictionary of Obstetrics and Gynecology, 1988)
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. Note that ENCLOMIPHENE and ZUCLOMIPHENE are the (E) and (Z) isomers of Clomiphene respectively.
The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.
Five individuals derived from five FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE).
Substances that provide protection against the harmful effects of freezing temperatures.
The small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains.
The developmental stage that follows BLASTULA or BLASTOCYST. It is characterized by the morphogenetic cell movements including invagination, ingression, and involution. Gastrulation begins with the formation of the PRIMITIVE STREAK, and ends with the formation of three GERM LAYERS, the body plan of the mature organism.
Four individuals derived from four FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.
The removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure.
The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
The processes occurring in early development that direct morphogenesis. They specify the body plan ensuring that cells will proceed to differentiate, grow, and diversify in size and shape at the correct relative positions. Included are axial patterning, segmentation, compartment specification, limb position, organ boundary patterning, blood vessel patterning, etc.
The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION.
Interfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as for the type of care provided.
A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
Validation of the SEX of an individual by inspection of the GONADS and/or by genetic tests.
A ubiquitous family of proteins that transport PHOSPHOLIPIDS such as PHOSPHATIDYLINOSITOL and PHOSPHATIDYLCHOLINE between membranes. They play an important role in phospholipid metabolism during vesicular transport and SIGNAL TRANSDUCTION.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE.
Delivery of the FETUS and PLACENTA under the care of an obstetrician or a health worker. Obstetric deliveries may involve physical, psychological, medical, or surgical interventions.
A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intrafallopian transfer of zygotes. (From Infertility and Reproductive Medicine Clinics of North America, Foreword 1990; Journal of Reproduction and Fertility, Notice to Contributors, Jan 1979)
The granulosa cells of the cumulus oophorus which surround the OVUM in the GRAAFIAN FOLLICLE. At OVULATION they are extruded with OVUM.
The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1).
DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
The development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.
Glycoproteins with the electrophoretic mobility of BETA-GLOBULINS, secreted by the placental TROPHOBLASTS into the maternal bloodstream during PREGNANCY. They can be detected 18 days after OVULATION and reach 200 mg/ml at the end of pregnancy. They are associated with fetal well-being.
Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus during the prenatal stage of development that is characterized by rapid morphological changes and the differentiation of basic structures. In humans, this includes the period from the time of fertilization to the end of the eighth week after fertilization.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients.
Chemical compounds causing LUTEOLYSIS or degeneration.
A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen.
Pregnancy in which the mother and/or FETUS are at greater than normal risk of MORBIDITY or MORTALITY. Causes include inadequate PRENATAL CARE, previous obstetrical history (ABORTION, SPONTANEOUS), pre-existing maternal disease, pregnancy-induced disease (GESTATIONAL HYPERTENSION), and MULTIPLE PREGNANCY, as well as advanced maternal age above 35.
An infant during the first month after birth.
Embryonic and fetal development that takes place in an artificial environment in vitro.
The middle germ layer of an embryo derived from three paired mesenchymal aggregates along the neural tube.
A water-soluble polypeptide (molecular weight approximately 8,000) extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. (Dorland, 28th ed)
Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities.
A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
The smooth muscle coat of the uterus, which forms the main mass of the organ.
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.
The outer of the three germ layers of an embryo.
Proteins that bind to and transfer CHOLESTEROL ESTERS between LIPOPROTEINS such as LOW-DENSITY LIPOPROTEINS and HIGH-DENSITY LIPOPROTEINS.
The capacity to conceive or to induce conception. It may refer to either the male or female.
The process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. (From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270)
The act of dilating.
Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.

Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. (1/2509)

Uterine peristalsis, directing sustained and rapid sperm transport from the external cervical os or the cervical crypts to the isthmic part of the tube ipsilateral to the dominant follicle, changes in direction and frequency during the menstrual cycle, with lowest activity during menstruation and highest activity at mid cycle. It was therefore suggested that uterine peristalsis is under the control of the dominant follicle with the additional involvement of oxytocin. To test this hypothesis, vaginal sonography of uterine peristalsis was performed in the early, mid and late proliferative phases, respectively, of cycles of women treated with oestradiol valerate and with human menopausal gonadotrophin following pituitary downregulation, with clomiphene citrate and with intravenous oxytocin, respectively. Administration of oestradiol valerate resulted in oestradiol serum concentrations comparable with the normal cycle with a simulation of the normal frequency of peristaltic contractions. Elevated oestradiol concentrations and bolus injections of oxytocin resulted in a significant increase in the frequency of peristaltic contractions in the early and mid follicular phases, respectively. Chlomiphene tended, though insignificantly so, to suppress the frequency of peristaltic waves in the presence of elevated oestradiol concentrations. In the late follicular phase of the cycle extremely elevated oestradiol concentrations as well as the injection of oxytocin resulted only in an insignificant further increase of peristaltic frequency. In the normal cycles, as well as during extremely elevated oestradiol concentrations and following oxytocin administration, the peristaltic contractions were always confined to the subendometrial layer of the muscular wall. The results and the review of literature indicate that uterine peristalsis during the follicular phase of the menstrual cycle is controlled by oestradiol released from the dominant follicle with the probable involvement of oxytocin, which is presumably stimulated together with its receptor within the endometrial-subendometrial unit and therefore acting in an autocrine/paracrine fashion. Since unphysiological stimulation with oestradiol and oxytocin did not significantly increase the frequency of uterine peristalsis in the late follicular phase of the cycle it is assumed that normal preovulatory frequency of uterine peristalsis is at a level which cannot be significantly surpassed due to phenomena of refractoriness of the system.  (+info)

Expression of calcium binding protein D-9k messenger RNA in the mouse uterine endometrium during implantation. (2/2509)

To investigate the molecular mechanisms of implantation, we constructed a cDNA library of mouse uteri enriched with pregnancy-induced genes by subtractive hybridization and polymerase chain reaction (PCR). One of the isolated clones was the cDNA for the calcium binding protein D-9k (Cabp9k), which is considered to regulate intracytoplasmic concentration and transport of free calcium ions. Northern blot and in-situ hybridization analyses demonstrated that the Cabp9k mRNA was expressed in the endometrial epithelia, both luminal and glandular, in the uterus at the time of implantation. On pregnancy day 5 it was detected in the luminal, but not in the glandular, epithelia. In the oophorectomized adult mice, progesterone enhanced Cabp9k mRNA expression in the uterus, whereas oestrogen did not. Consistent with this, a nucleotide change was identified in the first intron of mouse Cabp9k gene corresponding to the oestrogen responsive element in the rat Cabp9k gene. Transfer of embryos into the uterine cavity of pseudopregnant mice reduced the expression of Cabp9k mRNA in the glandular epithelium, suggesting that Cabp9k mRNA expression is also regulated by embryonal signal(s). These findings demonstrated that Cabp9k mRNA is expressed in the endometrial epithelia during the implantation period under the control of progesterone and the presence of embryo, and suggest that CaBP9k plays a role in implantation by regulating the local calcium concentrations.  (+info)

Production of germfree mice by embryo transfer. (3/2509)

We applied the embryo transfer technique to germfree (GF) mouse production. Embryos harvested from superovulated mice were transferred aseptically, in a sterile environment, to the uterus of GF recipient females which had been mated with vasectomized GF males. One of the recipients became pregnant and delivered offspring. Sterility tests confirmed that the vasectomized males, newborns, recipient female mice, embryo-containing culture media, and the inside of the vinyl film isolator were germfree. These results suggest that the embryo transfer technique can be successfully applied to the production of GF mice.  (+info)

Experimentally induced bovine spongiform encephalopathy did not transmit via goat embryos. (4/2509)

Goats are susceptible to experimental challenge with bovine spongiform encephalopathy (BSE). This study set out to investigate whether the transmission of BSE could occur in goats following the transfer of embryos from experimentally infected donor females into uninfected recipient females. The results showed no evidence of transmissible spongiform encephalopathy disease in any of the offspring which developed from embryos from infected donors, nor indeed in any of the recipient females used as surrogate dams. In addition, there was no indication of experimental BSE spreading as either a venereal infection to males used in mating or by maternal transmission to offspring born naturally to experimentally infected donors, although numbers were small.  (+info)

Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization-embryo transfer with normal semen analyses but failing hamster egg penetration assays? (5/2509)

PURPOSE: Our purpose was to assess whether in vitro fertilization (IVF)-embryo transfer (ET) candidate couples with basically normal semen analyses but failing zona-free hamster egg penetration assay (HEPA) scores benefit from intracytoplasmic sperm injection (ICSI). METHODS: Twenty consecutive IVF candidate couples with normal-borderline semen analyses and failing HEPA scores were recruited. Mature oocytes obtained from each woman were randomly divided between ICSI (group I; n = 126 oocytes) and standard insemination techniques (group II; 138 oocytes). Fertilization (two pronuclei) and cleavage (2-4 cells) rates were assessed for both groups. RESULTS: There were no statistically significant differences between the two groups with respect to (mean +/- standard error of the mean) fertilization (group I, 63.1 +/- 7.75; group II, 77.8 +/- 4.7%) or cleavage (group I, 87.3 +/- 2.4%; group II, 91.2 +/- 3.5%) rates. CONCLUSIONS: ICSI is not beneficial for IVF-ET when sperm samples demonstrate a failing HEPA score but have normal or minimally compromised semen analysis parameters.  (+info)

Retrieval, maturation, and fertilization of immature oocytes obtained from unstimulated patients with polycystic ovary syndrome. (6/2509)

PURPOSE: Our purpose was to determine whether immature oocytes could be retrieved under local anesthesia, whether these oocytes would mature and fertilize in vitro, and whether adequate endometrium development could be obtained after hormonal supplementation. METHODS: Ovum pick-up was performed under local anesthesia. Immature oocytes were cultured and inseminated. To prepare the endometrium, estradiolvalerate was administered in combination with micronized progesterone. RESULTS: Immature oocytes were obtained in all cases. Fifty-six percent (n = 30) of the oocytes developed into metaphase II (MII) after 48 hr of culture, and another 20% reached the MII stage by 72 hr. Normal fertilization was observed in only 10% of oocytes inseminated. No embryonic development occurred, and therefore embryo transfer was not performed in any of the patients. Endometrial microbiopsy was performed in all subjects and endometrial development was considered sufficient in eight patients. CONCLUSIONS: We collected immature oocytes from patients with polycystic ovary syndrome without general anesthesia. In vitro maturation of these oocytes seemed adequate but fertilization rates were poor. Sufficient endometrial quality was obtained after hormonal substitution.  (+info)

Enhanced hatching rate of bovine IVM/IVF/IVC blastocysts using a 1.48-micron diode laser beam. (7/2509)

PURPOSE: Our purpose was to test whether zona pellucida (ZP) drilling using a 1.48-micron diode laser beam on bovine IVM/IVF/IVC blastocysts is effective for embryo hatching. METHODS: Blastocysts produced in vitro at day 7 after IVF were divided into control and laser-drilled groups, respectively. RESULTS: When the rates of in vitro development of bovine embryos were examined, the average cleavage rate (> or = two-cell) was 82.3% and the blastocyst rate at day 7 after IVF was 32.5%. Using these blastocysts, when the laser drilling effect was investigated at 48 hr after treatment, the total hatching rate in the laser-drilled group (98.0%) was significantly higher than that in the control group (60.0%) (P < 0.001). Especially, the hatched rate of the laser-drilled group (68.0%) was significantly enhanced compared with that of the control group (30.0%) (P < 0.001). CONCLUSIONS: These results demonstrated that laser ZP drilling on bovine IVM/IVF/IVC blastocysts can significantly increase the hatching rate.  (+info)

Production of cloned calves following nuclear transfer with cultured adult mural granulosa cells. (8/2509)

Adult somatic cell nuclear transfer was used to determine the totipotent potential of cultured mural granulosa cells, obtained from a Friesian dairy cow of high genetic merit. Nuclei were exposed to oocyte cytoplasm for prolonged periods by electrically fusing quiescent cultured cells to enucleated metaphase II cytoplasts 4-6 h before activation (fusion before activation [FBA] treatment). Additionally, some first-generation morulae were recloned by fusing blastomeres to S-phase cytoplasts. A significantly higher proportion of fused embryos developed in vitro to grade 1-2 blastocysts on Day 7 with FBA (27.5 +/- 2.5%) than with recloning (13.0 +/- 3.6%; p < 0. 05). After the transfer of 100 blastocysts from the FBA treatment, survival rates on Days 60, 100, 180, and term were 45%, 21%, 17%, and 10%, respectively. Ten heifer calves were delivered by elective cesarean section; all have survived. After the transfer of 16 recloned blastocysts, embryo survival on Day 60 was 38%; however, no fetuses survived to Day 100. DNA analyses confirmed that the calves are all genetically identical to the donor cow. It is suggested that the losses throughout gestation may in part be due to placental dysfunction at specific stages. The next advance in this technology will be to introduce specific genetic modifications of biomedical or agricultural interest.  (+info)

Embryo transfer is a medical procedure that involves the transfer of an embryo, which is typically created through in vitro fertilization (IVF), into the uterus of a woman with the aim of establishing a pregnancy. The embryo may be created using the intended parent's own sperm and eggs or those from donors. After fertilization and early cell division, the resulting embryo is transferred into the uterus of the recipient mother through a thin catheter that is inserted through the cervix. This procedure is typically performed under ultrasound guidance to ensure proper placement of the embryo. Embryo transfer is a key step in assisted reproductive technology (ART) and is often used as a treatment for infertility.

Single embryo transfer (SET) is a medical procedure that involves the transplantation of a single embryo into a woman's uterus during in vitro fertilization (IVF) treatments. The aim of SET is to reduce the risk of multiple pregnancies, which can pose significant health risks to both the mother and the babies.

In IVF, multiple eggs are typically fertilized in the laboratory, resulting in several embryos. Traditionally, multiple embryos have been transferred into the uterus to increase the chances of a successful pregnancy. However, this approach also increases the risk of multiple pregnancies, which can lead to complications such as preterm labor, low birth weight, and gestational diabetes.

With SET, only one embryo is transferred, reducing the risk of multiple pregnancies while still providing a good chance of success in appropriately selected patients. The decision to perform SET is based on several factors, including the age and health of the patient, the quality of the embryos, and previous reproductive history.

Overall, single embryo transfer is a safe and effective way to increase the chances of a healthy singleton pregnancy while minimizing the risks associated with multiple pregnancies.

Fertilization in vitro, also known as in-vitro fertilization (IVF), is a medical procedure where an egg (oocyte) and sperm are combined in a laboratory dish to facilitate fertilization. The fertilized egg (embryo) is then transferred to a uterus with the hope of establishing a successful pregnancy. This procedure is often used when other assisted reproductive technologies have been unsuccessful or are not applicable, such as in cases of blocked fallopian tubes, severe male factor infertility, and unexplained infertility. The process involves ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer. In some cases, additional techniques such as intracytoplasmic sperm injection (ICSI) or preimplantation genetic testing (PGT) may be used to increase the chances of success.

The pregnancy rate is a measure used in reproductive medicine to determine the frequency or efficiency of conception following certain treatments, interventions, or under specific conditions. It is typically defined as the number of pregnancies per 100 women exposed to the condition being studied over a specified period of time. A pregnancy is confirmed when a woman has a positive result on a pregnancy test or through the detection of a gestational sac on an ultrasound exam.

In clinical trials and research, the pregnancy rate helps healthcare professionals evaluate the effectiveness of various fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), or ovulation induction medications. The pregnancy rate can also be used to assess the impact of lifestyle factors, environmental exposures, or medical conditions on fertility and conception.

It is important to note that pregnancy rates may vary depending on several factors, including age, the cause of infertility, the type and quality of treatment provided, and individual patient characteristics. Therefore, comparing pregnancy rates between different studies should be done cautiously, considering these potential confounding variables.

Embryo implantation is the process by which a fertilized egg, or embryo, becomes attached to the wall of the uterus (endometrium) and begins to receive nutrients from the mother's blood supply. This process typically occurs about 6-10 days after fertilization and is a critical step in the establishment of a successful pregnancy.

During implantation, the embryo secretes enzymes that help it to burrow into the endometrium, while the endometrium responds by producing receptors for the embryo's enzymes and increasing blood flow to the area. The embryo then begins to grow and develop, eventually forming the placenta, which will provide nutrients and oxygen to the developing fetus throughout pregnancy.

Implantation is a complex process that requires precise timing and coordination between the embryo and the mother's body. Factors such as age, hormonal imbalances, and uterine abnormalities can affect implantation and increase the risk of miscarriage or difficulty becoming pregnant.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

A mammalian embryo is the developing offspring of a mammal, from the time of implantation of the fertilized egg (blastocyst) in the uterus until the end of the eighth week of gestation. During this period, the embryo undergoes rapid cell division and organ differentiation to form a complex structure with all the major organs and systems in place. This stage is followed by fetal development, which continues until birth. The study of mammalian embryos is important for understanding human development, evolution, and reproductive biology.

Cryopreservation is a medical procedure that involves the preservation of cells, tissues, or organs by cooling them to very low temperatures, typically below -150°C. This is usually achieved using liquid nitrogen. The low temperature slows down or stops biological activity, including chemical reactions and cellular metabolism, which helps to prevent damage and decay.

The cells, tissues, or organs that are being cryopreserved must be treated with a cryoprotectant solution before cooling to prevent the formation of ice crystals, which can cause significant damage. Once cooled, the samples are stored in specialized containers or tanks until they are needed for use.

Cryopreservation is commonly used in assisted reproductive technologies, such as the preservation of sperm, eggs, and embryos for fertility treatments. It is also used in research, including the storage of cell lines and stem cells, and in clinical settings, such as the preservation of skin grafts and corneas for transplantation.

Multiple pregnancy is a type of gestation where more than one fetus is carried simultaneously in the uterus. The most common forms of multiple pregnancies are twins (two fetuses), triplets (three fetuses), and quadruplets (four fetuses). Multiple pregnancies can occur when a single fertilized egg splits into two or more embryos (monozygotic) or when more than one egg is released and gets fertilized during ovulation (dizygotic). The risk of multiple pregnancies increases with the use of assisted reproductive technologies, such as in vitro fertilization. Multiple pregnancies are associated with higher risks for both the mother and the fetuses, including preterm labor, low birth weight, and other complications.

Intracytoplasmic Sperm Injection (ICSI) is a specialized form of assisted reproductive technology (ART), specifically used in the context of in vitro fertilization (IVF). It involves the direct injection of a single sperm into the cytoplasm of a mature egg (oocyte) to facilitate fertilization. This technique is often used when there are issues with male infertility, such as low sperm count or poor sperm motility, to increase the chances of successful fertilization. The resulting embryos can then be transferred to the uterus in hopes of achieving a pregnancy.

Pregnancy outcome refers to the final result or status of a pregnancy, including both the health of the mother and the newborn baby. It can be categorized into various types such as:

1. Live birth: The delivery of one or more babies who show signs of life after separation from their mother.
2. Stillbirth: The delivery of a baby who has died in the womb after 20 weeks of pregnancy.
3. Miscarriage: The spontaneous loss of a pregnancy before the 20th week.
4. Abortion: The intentional termination of a pregnancy before the fetus can survive outside the uterus.
5. Ectopic pregnancy: A pregnancy that develops outside the uterus, usually in the fallopian tube, which is not viable and requires medical attention.
6. Preterm birth: The delivery of a baby before 37 weeks of gestation, which can lead to various health issues for the newborn.
7. Full-term birth: The delivery of a baby between 37 and 42 weeks of gestation.
8. Post-term pregnancy: The delivery of a baby after 42 weeks of gestation, which may increase the risk of complications for both mother and baby.

The pregnancy outcome is influenced by various factors such as maternal age, health status, lifestyle habits, genetic factors, and access to quality prenatal care.

A blastocyst is a stage in the early development of a fertilized egg, or embryo, in mammals. It occurs about 5-6 days after fertilization and consists of an outer layer of cells called trophoblasts, which will eventually form the placenta, and an inner cell mass, which will give rise to the fetus. The blastocyst is characterized by a fluid-filled cavity called the blastocoel. This stage is critical for the implantation of the embryo into the uterine lining.

A live birth is the complete expulsion or extraction from its mother of a product of human conception, irrespective of the duration of the pregnancy, that, after such separation, breathes or shows any other evidence of life - such as beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles - whether or not the umbilical cord has been cut or the placenta is attached.

This definition is used by the World Health Organization (WHO) and most national statistical agencies to distinguish live births from stillbirths. It's important to note that in some medical contexts, a different definition of live birth may be used.

Infertility is a reproductive health disorder defined as the failure to achieve a clinical pregnancy after 12 months or more of regular, unprotected sexual intercourse or due to an impairment of a person's capacity to reproduce either as an individual or with their partner. It can be caused by various factors in both men and women, including hormonal imbalances, structural abnormalities, genetic issues, infections, age, lifestyle factors, and others. Infertility can have significant emotional and psychological impacts on individuals and couples experiencing it, and medical intervention may be necessary to help them conceive.

Female infertility is a condition characterized by the inability to conceive after 12 months or more of regular, unprotected sexual intercourse or the inability to carry a pregnancy to a live birth. The causes of female infertility can be multifactorial and may include issues with ovulation, damage to the fallopian tubes or uterus, endometriosis, hormonal imbalances, age-related factors, and other medical conditions.

Some common causes of female infertility include:

1. Ovulation disorders: Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, premature ovarian failure, and hyperprolactinemia can affect ovulation and lead to infertility.
2. Damage to the fallopian tubes: Pelvic inflammatory disease, endometriosis, or previous surgeries can cause scarring and blockages in the fallopian tubes, preventing the egg and sperm from meeting.
3. Uterine abnormalities: Structural issues with the uterus, such as fibroids, polyps, or congenital defects, can interfere with implantation and pregnancy.
4. Age-related factors: As women age, their fertility declines due to a decrease in the number and quality of eggs.
5. Other medical conditions: Certain medical conditions, such as diabetes, celiac disease, and autoimmune disorders, can contribute to infertility.

In some cases, female infertility can be treated with medications, surgery, or assisted reproductive technologies (ART) like in vitro fertilization (IVF). A thorough evaluation by a healthcare professional is necessary to determine the underlying cause and develop an appropriate treatment plan.

A nonmammalian embryo refers to the developing organism in animals other than mammals, from the fertilized egg (zygote) stage until hatching or birth. In nonmammalian species, the developmental stages and terminology differ from those used in mammals. The term "embryo" is generally applied to the developing organism up until a specific stage of development that is characterized by the formation of major organs and structures. After this point, the developing organism is referred to as a "larva," "juvenile," or other species-specific terminology.

The study of nonmammalian embryos has played an important role in our understanding of developmental biology and evolutionary developmental biology (evo-devo). By comparing the developmental processes across different animal groups, researchers can gain insights into the evolutionary origins and diversification of body plans and structures. Additionally, nonmammalian embryos are often used as model systems for studying basic biological processes, such as cell division, gene regulation, and pattern formation.

Ovulation induction is a medical procedure that involves the stimulation of ovulation (the release of an egg from the ovaries) in women who have difficulties conceiving due to ovulatory disorders. This is typically achieved through the use of medications such as clomiphene citrate or gonadotropins, which promote the development and maturation of follicles in the ovaries containing eggs. The process is closely monitored through regular ultrasounds and hormone tests to ensure appropriate response and minimize the risk of complications like multiple pregnancies. Ovulation induction may be used as a standalone treatment or in conjunction with other assisted reproductive technologies (ART), such as intrauterine insemination (IUI) or in vitro fertilization (IVF).

A chick embryo refers to the developing organism that arises from a fertilized chicken egg. It is often used as a model system in biological research, particularly during the stages of development when many of its organs and systems are forming and can be easily observed and manipulated. The study of chick embryos has contributed significantly to our understanding of various aspects of developmental biology, including gastrulation, neurulation, organogenesis, and pattern formation. Researchers may use various techniques to observe and manipulate the chick embryo, such as surgical alterations, cell labeling, and exposure to drugs or other agents.

The cleavage stage of an ovum, also known as a fertilized egg, refers to the series of rapid cell divisions that occur after fertilization. During this stage, the single cell (zygote) divides into multiple cells, forming a blastomere. This process occurs in the fallopian tube and continues until the blastocyst reaches the uterus, typically around 5-6 days after fertilization. The cleavage stage is a critical period in early embryonic development, as any abnormalities during this time can lead to implantation failure or developmental defects.

Zygote Intrafallopian Transfer (ZIFT) is a type of assisted reproductive technology (ART) that involves the transfer of a fertilized egg, or zygote, into the fallopian tube. The procedure is typically used to help individuals or couples who have difficulty conceiving naturally.

The ZIFT process begins with the retrieval of eggs from the ovaries through a minor surgical procedure called follicular aspiration. These eggs are then fertilized in a laboratory with sperm from the partner or a donor. The resulting zygotes are allowed to grow for about 24 hours, at which point they have typically divided into two cells.

The next step is to transfer the zygotes into the fallopian tubes using a thin catheter. This procedure is usually performed under sedation or anesthesia and takes only a few minutes. The goal of ZIFT is to place the zygotes in the optimal location for implantation and pregnancy to occur.

ZIFT has a slightly higher success rate than other forms of ART, such as in vitro fertilization (IVF), because it places the embryos closer to the site of implantation. However, ZIFT also carries a higher risk of complications, including ectopic pregnancy and infection.

It's important to note that ZIFT is not a common procedure due to the complexity of the process and the availability of other less invasive options like IVF. The decision to undergo ZIFT should be made in consultation with a fertility specialist and based on individual circumstances and medical history.

In the field of medicine, twins are defined as two offspring produced by the same pregnancy. They can be either monozygotic (identical) or dizygotic (fraternal). Monozygotic twins develop from a single fertilized egg that splits into two separate embryos, resulting in individuals who share identical genetic material. Dizygotic twins, on the other hand, result from the fertilization of two separate eggs by two different sperm cells, leading to siblings who share about 50% of their genetic material, similar to non-twin siblings.

Oocyte donation is a medical procedure in which mature oocytes (or immature oocytes that are matured in the lab) are donated by one woman to another woman for the purpose of assisted reproduction. The recipient woman typically receives hormonal treatments to prepare her uterus for embryo implantation. The donated oocytes are then fertilized with sperm from the recipient's partner or a sperm donor in a laboratory, and the resulting embryos are transferred into the recipient's uterus.

Oocyte donation is often recommended for women who have poor ovarian function or who have a high risk of passing on genetic disorders to their offspring. It is also used in cases where previous attempts at in vitro fertilization (IVF) using the woman's own eggs have been unsuccessful.

The process of oocyte donation involves rigorous screening and evaluation of both the donor and recipient, including medical, psychological, and genetic evaluations, to ensure the safety and success of the procedure. The donor's ovaries are stimulated with hormonal medications to produce multiple mature oocytes, which are then retrieved through a minor surgical procedure.

Overall, oocyte donation is a complex and emotionally charged process that requires careful consideration and counseling for both the donor and recipient. It offers hope for many women who would otherwise be unable to conceive a biological child.

Assisted reproductive techniques (ART) are medical procedures that involve the handling of human sperm and ova to establish a pregnancy. These techniques are used when other methods of achieving pregnancy have failed or are not available. Examples of ART include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). These procedures may be used to treat infertility, prevent genetic disorders, or to help same-sex couples or single people have children. It is important to note that the use of ART can involve significant physical, emotional, and financial costs, and it may not always result in a successful pregnancy.

Reproductive techniques refer to various methods and procedures used to assist individuals or couples in achieving pregnancy, carrying a pregnancy to term, or preserving fertility. These techniques can be broadly categorized into assisted reproductive technology (ART) and fertility preservation.

Assisted reproductive technology (ART) includes procedures such as:

1. In vitro fertilization (IVF): A process where an egg is fertilized by sperm outside the body in a laboratory dish, and then the resulting embryo is transferred to a woman's uterus.
2. Intracytoplasmic sperm injection (ICSI): A procedure where a single sperm is directly injected into an egg to facilitate fertilization.
3. Embryo culture and cryopreservation: The process of growing embryos in a laboratory for a few days before freezing them for later use.
4. Donor gametes: Using eggs, sperm, or embryos from a known or anonymous donor to achieve pregnancy.
5. Gestational surrogacy: A method where a woman carries and gives birth to a baby for another individual or couple who cannot carry a pregnancy themselves.

Fertility preservation techniques include:

1. Sperm banking: The process of freezing and storing sperm for future use in artificial reproduction.
2. Egg (oocyte) freezing: A procedure where a woman's eggs are extracted, frozen, and stored for later use in fertility treatments.
3. Embryo freezing: The cryopreservation of embryos created through IVF for future use.
4. Ovarian tissue cryopreservation: The freezing and storage of ovarian tissue to restore fertility after cancer treatment or other conditions that may affect fertility.
5. Testicular tissue cryopreservation: The collection and storage of testicular tissue in prepubertal boys undergoing cancer treatment to preserve their future fertility potential.

Embryonic development is the series of growth and developmental stages that occur during the formation and early growth of the embryo. In humans, this stage begins at fertilization (when the sperm and egg cell combine) and continues until the end of the 8th week of pregnancy. During this time, the fertilized egg (now called a zygote) divides and forms a blastocyst, which then implants into the uterus. The cells in the blastocyst begin to differentiate and form the three germ layers: the ectoderm, mesoderm, and endoderm. These germ layers will eventually give rise to all of the different tissues and organs in the body.

Embryonic development is a complex and highly regulated process that involves the coordinated interaction of genetic and environmental factors. It is characterized by rapid cell division, migration, and differentiation, as well as programmed cell death (apoptosis) and tissue remodeling. Abnormalities in embryonic development can lead to birth defects or other developmental disorders.

It's important to note that the term "embryo" is used to describe the developing organism from fertilization until the end of the 8th week of pregnancy in humans, after which it is called a fetus.

Embryonic and fetal development is the process of growth and development that occurs from fertilization of the egg (conception) to birth. The terms "embryo" and "fetus" are used to describe different stages of this development:

* Embryonic development: This stage begins at fertilization and continues until the end of the 8th week of pregnancy. During this time, the fertilized egg (zygote) divides and forms a blastocyst, which implants in the uterus and begins to develop into a complex structure called an embryo. The embryo consists of three layers of cells that will eventually form all of the organs and tissues of the body. During this stage, the basic structures of the body, including the nervous system, heart, and gastrointestinal tract, begin to form.
* Fetal development: This stage begins at the end of the 8th week of pregnancy and continues until birth. During this time, the embryo is called a fetus, and it grows and develops rapidly. The organs and tissues that were formed during the embryonic stage continue to mature and become more complex. The fetus also begins to move and kick, and it can hear and respond to sounds from outside the womb.

Overall, embryonic and fetal development is a complex and highly regulated process that involves the coordinated growth and differentiation of cells and tissues. It is a critical period of development that lays the foundation for the health and well-being of the individual throughout their life.

Blastomeres are early stage embryonic cells that result from the initial rounds of cell division in a fertilized egg, also known as a zygote. These cells are typically smaller and have a more simple organization compared to more mature cells. They are important for the normal development of the embryo and contribute to the formation of the blastocyst, which is an early stage embryonic structure that will eventually give rise to the fetus. The process of cell division that produces blastomeres is called cleavage.

Spontaneous abortion, also known as miscarriage, is the unintentional expulsion of a nonviable fetus from the uterus before the 20th week of gestation. It is a common complication of early pregnancy, with most miscarriages occurring during the first trimester. Spontaneous abortion can have various causes, including chromosomal abnormalities, maternal health conditions, infections, hormonal imbalances, and structural issues of the uterus or cervix. In many cases, the exact cause may remain unknown.

The symptoms of spontaneous abortion can vary but often include vaginal bleeding, which may range from light spotting to heavy bleeding; abdominal pain or cramping; and the passing of tissue or clots from the vagina. While some miscarriages occur suddenly and are immediately noticeable, others may progress slowly over several days or even weeks.

In medical practice, healthcare providers often use specific terminology to describe different stages and types of spontaneous abortion. For example:

* Threatened abortion: Vaginal bleeding during early pregnancy, but the cervix remains closed, and there is no evidence of fetal demise or passing of tissue.
* Inevitable abortion: Vaginal bleeding with an open cervix, indicating that a miscarriage is imminent or already in progress.
* Incomplete abortion: The expulsion of some but not all products of conception from the uterus, requiring medical intervention to remove any remaining tissue.
* Complete abortion: The successful passage of all products of conception from the uterus, often confirmed through an ultrasound or pelvic examination.
* Missed abortion: The death of a fetus in the uterus without any expulsion of the products of conception, which may be discovered during routine prenatal care.
* Septic abortion: A rare and life-threatening complication of spontaneous abortion characterized by infection of the products of conception and the surrounding tissues, requiring prompt medical attention and antibiotic treatment.

Healthcare providers typically monitor patients who experience a spontaneous abortion to ensure that all products of conception have been expelled and that there are no complications, such as infection or excessive bleeding. In some cases, medication or surgical intervention may be necessary to remove any remaining tissue or address other issues related to the miscarriage. Counseling and support services are often available for individuals and couples who experience a spontaneous abortion, as they may face emotional challenges and concerns about future pregnancies.

An oocyte, also known as an egg cell or female gamete, is a large specialized cell found in the ovary of female organisms. It contains half the number of chromosomes as a normal diploid cell, as it is the product of meiotic division. Oocytes are surrounded by follicle cells and are responsible for the production of female offspring upon fertilization with sperm. The term "oocyte" specifically refers to the immature egg cell before it reaches full maturity and is ready for fertilization, at which point it is referred to as an ovum or egg.

Chorionic Gonadotropin (hCG) is a hormone that is produced during pregnancy. It is produced by the placenta after implantation of the fertilized egg in the uterus. The main function of hCG is to prevent the disintegration of the corpus luteum, which is a temporary endocrine structure that forms in the ovary after ovulation and produces progesterone during early pregnancy. Progesterone is essential for maintaining the lining of the uterus and supporting the pregnancy.

hCG can be detected in the blood or urine as early as 10 days after conception, and its levels continue to rise throughout the first trimester of pregnancy. In addition to its role in maintaining pregnancy, hCG is also used as a clinical marker for pregnancy and to monitor certain medical conditions such as gestational trophoblastic diseases.

Embryo culture techniques refer to the methods and procedures used to maintain and support the growth and development of an embryo outside of the womb, typically in a laboratory setting. These techniques are often used in the context of assisted reproductive technologies (ART), such as in vitro fertilization (IVF).

The process typically involves fertilizing an egg with sperm in a laboratory dish and then carefully monitoring and maintaining the resulting embryo in a specialized culture medium that provides the necessary nutrients, hormones, and other factors to support its development. The culture medium is usually contained within an incubator that maintains optimal temperature, humidity, and gas concentrations to mimic the environment inside the body.

Embryologists may use various embryo culture techniques depending on the stage of development and the specific needs of the embryo. For example, some techniques involve culturing the embryo in a single layer, while others may use a technique called "co-culture" that involves growing the embryo on a layer of cells to provide additional support and nutrients.

The goal of embryo culture techniques is to promote the healthy growth and development of the embryo, increasing the chances of a successful pregnancy and live birth. However, it's important to note that these techniques are not without risk, and there are potential ethical considerations surrounding the use of ART and embryo culture.

The birth rate is the number of live births that occur in a population during a specific period, usually calculated as the number of live births per 1,000 people per year. It is an important demographic indicator used to measure the growth or decline of a population over time. A higher birth rate indicates a younger population and faster population growth, while a lower birth rate suggests an older population and slower growth.

The birth rate can be affected by various factors, including socioeconomic conditions, cultural attitudes towards childbearing, access to healthcare services, and government policies related to family planning and reproductive health. It is also influenced by the age structure of the population, as women in their reproductive years (typically ages 15-49) are more likely to give birth.

It's worth noting that while the birth rate is an important indicator of population growth, it does not provide a complete picture of fertility rates or demographic trends. Other measures, such as the total fertility rate (TFR), which estimates the average number of children a woman would have during her reproductive years, are also used to analyze fertility patterns and population dynamics.

Preimplantation Diagnosis (PID) is a genetic testing procedure performed on embryos created through in vitro fertilization (IVF), before they are implanted in the uterus. The purpose of PID is to identify genetic disorders or chromosomal abnormalities in the embryos, allowing only those free of such issues to be transferred to the uterus, thereby reducing the risk of passing on genetic diseases to offspring. It involves biopsying one or more cells from an embryo and analyzing its DNA for specific genetic disorders or chromosomal abnormalities. PID is often recommended for couples with a known history of genetic disorders or those who have experienced multiple miscarriages or failed IVF cycles.

A morula is a term used in embryology, which refers to the early stage of development in mammalian embryos. It is formed after fertilization when the zygote (a single cell resulting from the fusion of sperm and egg) undergoes several rounds of mitotic divisions to form a solid mass of 16 or more cells called blastomeres. At this stage, the cells are tightly packed together and have a compact, mulberry-like appearance, hence the name "morula" which is derived from the Latin word for "mulberry."

The morula stage typically occurs about 4-5 days after fertilization in humans and is marked by the beginning of blastulation, where the cells start to differentiate and become organized into an outer layer (trophoblast) and an inner cell mass. The trophoblast will eventually form the placenta, while the inner cell mass will give rise to the embryo proper.

It's important to note that the morula stage is a transient phase in embryonic development, and it represents a critical period of growth and differentiation as the embryo prepares for implantation into the uterine wall.

Gene transfer techniques, also known as gene therapy, refer to medical procedures where genetic material is introduced into an individual's cells or tissues to treat or prevent diseases. This can be achieved through various methods:

1. **Viral Vectors**: The most common method uses modified viruses, such as adenoviruses, retroviruses, or lentiviruses, to carry the therapeutic gene into the target cells. The virus infects the cell and inserts the new gene into the cell's DNA.

2. **Non-Viral Vectors**: These include methods like electroporation (using electric fields to create pores in the cell membrane), gene guns (shooting gold particles coated with DNA into cells), or liposomes (tiny fatty bubbles that can enclose DNA).

3. **Direct Injection**: In some cases, the therapeutic gene can be directly injected into a specific tissue or organ.

The goal of gene transfer techniques is to supplement or replace a faulty gene with a healthy one, thereby correcting the genetic disorder. However, these techniques are still largely experimental and have their own set of challenges, including potential immune responses, issues with accurate targeting, and risks of mutations or cancer development.

Ovarian Hyperstimulation Syndrome (OHSS) is a medical condition characterized by the enlargement of the ovaries and the accumulation of fluid in the abdominal cavity, which can occur as a complication of fertility treatments that involve the use of medications to stimulate ovulation.

In OHSS, the ovaries become swollen and may contain multiple follicles (small sacs containing eggs) that have developed in response to the hormonal stimulation. This can lead to the release of large amounts of vasoactive substances, such as vascular endothelial growth factor (VEGF), which can cause increased blood flow to the ovaries and fluid leakage from the blood vessels into the abdominal cavity.

Mild cases of OHSS may cause symptoms such as bloating, abdominal pain or discomfort, nausea, and diarrhea. More severe cases can lead to more serious complications, including blood clots, kidney failure, and respiratory distress. In extreme cases, hospitalization may be necessary to manage the symptoms of OHSS and prevent further complications.

OHSS is typically managed by monitoring the patient's symptoms and providing supportive care, such as fluid replacement and pain management. In severe cases, medication or surgery may be necessary to drain excess fluid from the abdominal cavity. Preventive measures, such as adjusting the dosage of fertility medications or canceling treatment cycles, may also be taken to reduce the risk of OHSS in high-risk patients.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Menotropins are a preparation of natural follicle-stimulating hormone (FSH) and luteinizing hormone (LH) derived from the urine of postmenopausal women. They are used in infertility treatment to stimulate the development of multiple follicles in the ovaries, leading to an increased chance of pregnancy through assisted reproductive technologies such as in vitro fertilization (IVF).

Menotropins contain a mixture of FSH and LH in a ratio that is similar to the natural hormone levels found in the human body. The FSH component stimulates the growth and development of follicles in the ovaries, while the LH component triggers ovulation when the follicles have matured.

Menotropins are typically administered by subcutaneous injection and are available under various brand names, such as Menopur and Repronex. The use of menotropins requires careful medical supervision to monitor the response of the ovaries and to minimize the risk of complications such as ovarian hyperstimulation syndrome (OHSS).

Vitrification is a process used in cryopreservation, where a liquid or semi-liquid biological material is transformed into a glass-like solid state by cooling it to extremely low temperatures at a rate that suppresses the formation of ice crystals. This technique is often used in assisted reproductive technology (ART) for preserving oocytes (human eggs), embryos, and ovarian or testicular tissues.

During vitrification, the biological material is exposed to high concentrations of cryoprotectants, which help prevent ice crystal formation and minimize cellular damage during cooling. The sample is then rapidly cooled using liquid nitrogen, achieving temperatures below -150°C (-238°F) in a matter of seconds or minutes.

The primary advantage of vitrification over traditional slow-freezing methods is the elimination of ice crystal formation, which can cause significant damage to cellular structures and organelles. Vitrified samples maintain their structural integrity and have higher survival rates upon thawing, making them more suitable for use in ART procedures.

However, it's important to note that vitrification also has potential risks, such as the toxicity of high cryoprotectant concentrations and the possibility of cracking during cooling or warming due to thermal stress. Proper technique and careful handling are crucial to ensure successful vitrification and subsequent use in clinical applications.

Embryo loss is a medical term that refers to the miscarriage or spontaneous abortion of an embryo, which is the developing offspring from the time of fertilization until the end of the eighth week of pregnancy. Embryo loss can occur at any point during this period and may be caused by various factors such as chromosomal abnormalities, maternal health issues, infections, environmental factors, or lifestyle habits.

Embryo loss is a common occurrence, with up to 30% of pregnancies ending in miscarriage, many of which happen before the woman even realizes she is pregnant. In most cases, embryo loss is a natural process that occurs when the body detects an abnormality or problem with the developing embryo and terminates the pregnancy to prevent further complications. However, recurrent embryo loss can be a sign of underlying medical issues and may require further evaluation and treatment.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Cloning of an organism is the process of creating a genetically identical copy of an entire living organism, including all of its DNA. This is achieved through a variety of laboratory techniques that can vary depending on the type of organism being cloned. In the case of animals, one common method is called somatic cell nuclear transfer (SCNT).

In SCNT, the nucleus of a donor animal's cell (which contains its DNA) is removed and transferred into an egg cell that has had its own nucleus removed. The egg cell is then stimulated to divide and grow, resulting in an embryo that is genetically identical to the donor animal. This embryo can be implanted into a surrogate mother, where it will continue to develop until birth.

Cloning of organisms has raised ethical concerns and debates, particularly in the case of animals, due to questions about the welfare of cloned animals and the potential implications for human cloning. However, cloning is also seen as having potential benefits, such as the ability to produce genetically identical animals for research or agricultural purposes.

It's important to note that while cloning can create genetically identical organisms, it does not necessarily mean that they will be identical in every way, as environmental factors and random genetic mutations can still result in differences between clones.

Fallopian tube diseases refer to conditions that affect the function or structure of the Fallopian tubes, which are a pair of narrow tubes that transport the egg from the ovaries to the uterus during ovulation and provide a pathway for sperm to reach the egg for fertilization. Some common Fallopian tube diseases include:

1. Salpingitis: This is an inflammation of the Fallopian tubes, usually caused by an infection. The infection can be bacterial, viral, or fungal in origin and can lead to scarring, blockage, or damage to the Fallopian tubes.
2. Hydrosalpinx: This is a condition where one or both of the Fallopian tubes become filled with fluid, leading to swelling and distension of the tube. The cause of hydrosalpinx can be infection, endometriosis, or previous surgery.
3. Endometriosis: This is a condition where the tissue that lines the inside of the uterus grows outside of it, including on the Fallopian tubes. This can lead to scarring, adhesions, and blockage of the tubes.
4. Ectopic pregnancy: This is a pregnancy that develops outside of the uterus, usually in the Fallopian tube. An ectopic pregnancy can cause the Fallopian tube to rupture, leading to severe bleeding and potentially life-threatening complications.
5. Tubal ligation: This is a surgical procedure that involves blocking or cutting the Fallopian tubes to prevent pregnancy. In some cases, tubal ligation can lead to complications such as ectopic pregnancy or tubal sterilization syndrome, which is a condition where the fallopian tubes reconnect and allow for pregnancy to occur.

These conditions can cause infertility, chronic pain, and other health problems, and may require medical or surgical treatment.

Oocyte retrieval is a medical procedure that is performed to obtain mature eggs (oocytes) from the ovaries of a female patient, typically for the purpose of assisted reproductive technologies (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

During the procedure, which is usually done under sedation or anesthesia, a thin needle is inserted through the vaginal wall and guided into the ovarian follicles using ultrasound imaging. The mature eggs are then gently aspirated from the follicles and collected in a test tube.

Oocyte retrieval is typically performed after several days of hormonal stimulation, which helps to promote the development and maturation of multiple eggs within the ovaries. After the procedure, the eggs are examined for maturity and quality before being fertilized with sperm in the laboratory. The resulting embryos are then transferred to the uterus or frozen for future use.

It's important to note that oocyte retrieval carries some risks, including bleeding, infection, and damage to surrounding organs. However, these complications are generally rare and can be minimized with careful monitoring and skilled medical care.

Ectopic pregnancy is a type of abnormal pregnancy that occurs outside the uterine cavity. The most common site for an ectopic pregnancy is the fallopian tube, accounting for about 95% of cases. This condition is also known as tubal pregnancy. Other less common sites include the ovary, cervix, and abdominal cavity.

In a normal pregnancy, the fertilized egg travels down the fallopian tube and implants itself in the lining of the uterus. However, in an ectopic pregnancy, the fertilized egg implants and starts to develop somewhere other than the uterus. The growing embryo cannot survive outside the uterus, and if left untreated, an ectopic pregnancy can cause life-threatening bleeding due to the rupture of the fallopian tube or other organs.

Symptoms of ectopic pregnancy may include abdominal pain, vaginal bleeding, shoulder pain, lightheadedness, fainting, and in severe cases, shock. Diagnosis is usually made through a combination of medical history, physical examination, ultrasound, and blood tests to measure the levels of human chorionic gonadotropin (hCG), a hormone produced during pregnancy.

Treatment for ectopic pregnancy depends on several factors, including the location, size, and growth rate of the ectopic mass, as well as the patient's overall health and desire for future pregnancies. Treatment options may include medication to stop the growth of the embryo or surgery to remove the ectopic tissue. In some cases, both methods may be used together. Early diagnosis and treatment can help prevent serious complications and improve the chances of preserving fertility in future pregnancies.

Superovulation, also known as controlled ovarian stimulation (COS), refers to the process of inducing the development and release of multiple mature ova (eggs) from the ovaries during a single reproductive cycle. This is achieved through the administration of exogenous gonadotropins or other fertility medications, which stimulate the ovarian follicles to grow and mature beyond the normal number. Superovulation is commonly used in assisted reproductive technologies (ART) such as in vitro fertilization (IVF) to increase the chances of successful conception by obtaining a larger number of ova for fertilization and embryo transfer.

Nuclear transfer techniques are scientific procedures that involve the transfer of the nucleus of a cell, containing its genetic material, from one cell to another. The most well-known type of nuclear transfer is somatic cell nuclear transfer (SCNT), which is used in therapeutic cloning and reproductive cloning.

In SCNT, the nucleus of a somatic cell (a body cell, not an egg or sperm cell) is transferred into an enucleated egg cell (an egg cell from which the nucleus has been removed). The egg cell with the new nucleus is then stimulated to divide and grow, creating an embryo that is genetically identical to the donor of the somatic cell.

Nuclear transfer techniques have various potential applications in medicine, including the creation of patient-specific stem cells for use in regenerative medicine, drug development and testing, and the study of genetic diseases. However, these procedures are also associated with ethical concerns, particularly in relation to reproductive cloning and the creation of human embryos for research purposes.

Maternal age is a term used to describe the age of a woman at the time she becomes pregnant or gives birth. It is often used in medical and epidemiological contexts to discuss the potential risks, complications, and outcomes associated with pregnancy and childbirth at different stages of a woman's reproductive years.

Advanced maternal age typically refers to women who become pregnant or give birth at 35 years of age or older. This group faces an increased risk for certain chromosomal abnormalities, such as Down syndrome, and other pregnancy-related complications, including gestational diabetes, preeclampsia, and cesarean delivery.

On the other end of the spectrum, adolescent pregnancies (those that occur in women under 20 years old) also come with their own set of potential risks and complications, such as preterm birth, low birth weight, and anemia.

It's important to note that while maternal age can influence pregnancy outcomes, many other factors – including genetics, lifestyle choices, and access to quality healthcare – can also play a significant role in determining the health of both mother and baby during pregnancy and childbirth.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Artificial insemination (AI) is a medical procedure that involves the introduction of sperm into a female's cervix or uterus for the purpose of achieving pregnancy. This procedure can be performed using sperm from a partner or a donor. It is often used when there are issues with male fertility, such as low sperm count or poor sperm motility, or in cases where natural conception is not possible due to various medical reasons.

There are two types of artificial insemination: intracervical insemination (ICI) and intrauterine insemination (IUI). ICI involves placing the sperm directly into the cervix, while IUI involves placing the sperm directly into the uterus using a catheter. The choice of procedure depends on various factors, including the cause of infertility and the preferences of the individuals involved.

Artificial insemination is a relatively simple and low-risk procedure that can be performed in a doctor's office or clinic. It may be combined with fertility drugs to increase the chances of pregnancy. The success rate of artificial insemination varies depending on several factors, including the age and fertility of the individuals involved, the cause of infertility, and the type of procedure used.

Pregnancy reduction, multifetal refers to the medical procedure used to decrease the number of fetuses in a multiple pregnancy, such as twins or higher-order multiples (triplets, quadruplets, etc.). This is also known as selective reduction or selective termination. The goal of this procedure is to reduce the risk of complications associated with multifetal pregnancies, including preterm labor, low birth weight, and pregnancy loss.

The procedure typically involves an ultrasound-guided injection of a medication that stops the development of one or more fetuses. This is usually performed during the first trimester of pregnancy. The decision to undergo pregnancy reduction is often based on a variety of factors, including maternal age, medical history, and personal preferences. It's important to note that this procedure carries its own risks, such as infection, bleeding, and loss of the remaining fetuses, so it should be carefully considered and discussed with healthcare providers.

Buserelin is a synthetic analogue of gonadotropin-releasing hormone (GnRH or LHRH), which is a hormonal drug used in the treatment of various conditions such as endometriosis, uterine fibroids, prostate cancer, and central precocious puberty.

By mimicking the action of natural GnRH, buserelin stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn regulates the production of sex hormones such as estrogen and testosterone.

However, prolonged use of buserelin leads to downregulation of GnRH receptors and a decrease in FSH and LH secretion, resulting in reduced levels of sex hormones. This property is exploited in the treatment of hormone-dependent cancers such as prostate cancer, where reducing testosterone levels can help slow tumor growth.

Buserelin is available in various forms, including nasal sprays, implants, and injectable solutions, and its use should be under the supervision of a healthcare professional due to potential side effects and the need for careful monitoring of hormone levels during treatment.

Fertilization is the process by which a sperm cell (spermatozoon) penetrates and fuses with an egg cell (ovum), resulting in the formation of a zygote. This fusion of genetic material from both the male and female gametes initiates the development of a new organism. In human biology, fertilization typically occurs in the fallopian tube after sexual intercourse, when a single sperm out of millions is able to reach and penetrate the egg released from the ovary during ovulation. The successful fusion of these two gametes marks the beginning of pregnancy.

Zona pellucida is a term used in the field of reproductive biology and it refers to the glycoprotein membrane that surrounds mammalian oocytes (immature egg cells). This membrane plays a crucial role in the fertilization process. It has receptors for sperm, and upon binding with the sperm, it undergoes changes that prevent other sperm from entering, a process known as the zona reaction. This membrane is also involved in the early development of the embryo.

Horizontal gene transfer (HGT), also known as lateral gene transfer, is the movement of genetic material between organisms in a manner other than from parent to offspring (vertical gene transfer). In horizontal gene transfer, an organism can take up genetic material directly from its environment and incorporate it into its own genome. This process is common in bacteria and archaea, but has also been observed in eukaryotes including plants and animals.

Horizontal gene transfer can occur through several mechanisms, including:

1. Transformation: the uptake of free DNA from the environment by a cell.
2. Transduction: the transfer of genetic material between cells by a virus (bacteriophage).
3. Conjugation: the direct transfer of genetic material between two cells in physical contact, often facilitated by a conjugative plasmid or other mobile genetic element.

Horizontal gene transfer can play an important role in the evolution and adaptation of organisms, allowing them to acquire new traits and functions rapidly. It is also of concern in the context of genetically modified organisms (GMOs) and antibiotic resistance, as it can facilitate the spread of genes that confer resistance or other undesirable traits.

Twin pregnancy refers to a type of multiple pregnancy where a woman is carrying two fetuses simultaneously. There are two types of twin pregnancies: monozygotic (identical) and dizygotic (fraternal). Monoygotic twins occur when a single fertilized egg (zygote) splits and develops into two separate embryos, resulting in identical twins who share the same genetic material. Dizygotic twins, on the other hand, result from the fertilization of two separate eggs by two different sperm cells, leading to non-identical twins who have their own unique genetic material.

Twin pregnancies are associated with higher risks of complications compared to singleton pregnancies, including preterm labor, low birth weight, gestational diabetes, and preeclampsia. Close monitoring by healthcare providers is essential to ensure the best possible outcomes for both the mother and the twins.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Catheterization is a medical procedure in which a catheter (a flexible tube) is inserted into the body to treat various medical conditions or for diagnostic purposes. The specific definition can vary depending on the area of medicine and the particular procedure being discussed. Here are some common types of catheterization:

1. Urinary catheterization: This involves inserting a catheter through the urethra into the bladder to drain urine. It is often performed to manage urinary retention, monitor urine output in critically ill patients, or assist with surgical procedures.
2. Cardiac catheterization: A procedure where a catheter is inserted into a blood vessel, usually in the groin or arm, and guided to the heart. This allows for various diagnostic tests and treatments, such as measuring pressures within the heart chambers, assessing blood flow, or performing angioplasty and stenting of narrowed coronary arteries.
3. Central venous catheterization: A catheter is inserted into a large vein, typically in the neck, chest, or groin, to administer medications, fluids, or nutrition, or to monitor central venous pressure.
4. Peritoneal dialysis catheterization: A catheter is placed into the abdominal cavity for individuals undergoing peritoneal dialysis, a type of kidney replacement therapy.
5. Neurological catheterization: In some cases, a catheter may be inserted into the cerebrospinal fluid space (lumbar puncture) or the brain's ventricular system (ventriculostomy) to diagnose or treat various neurological conditions.

These are just a few examples of catheterization procedures in medicine. The specific definition and purpose will depend on the medical context and the particular organ or body system involved.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Culture techniques are methods used in microbiology to grow and multiply microorganisms, such as bacteria, fungi, or viruses, in a controlled laboratory environment. These techniques allow for the isolation, identification, and study of specific microorganisms, which is essential for diagnostic purposes, research, and development of medical treatments.

The most common culture technique involves inoculating a sterile growth medium with a sample suspected to contain microorganisms. The growth medium can be solid or liquid and contains nutrients that support the growth of the microorganisms. Common solid growth media include agar plates, while liquid growth media are used for broth cultures.

Once inoculated, the growth medium is incubated at a temperature that favors the growth of the microorganisms being studied. During incubation, the microorganisms multiply and form visible colonies on the solid growth medium or turbid growth in the liquid growth medium. The size, shape, color, and other characteristics of the colonies can provide important clues about the identity of the microorganism.

Other culture techniques include selective and differential media, which are designed to inhibit the growth of certain types of microorganisms while promoting the growth of others, allowing for the isolation and identification of specific pathogens. Enrichment cultures involve adding specific nutrients or factors to a sample to promote the growth of a particular type of microorganism.

Overall, culture techniques are essential tools in microbiology and play a critical role in medical diagnostics, research, and public health.

A zygote is the initial cell formed when a sperm fertilizes an egg, also known as an oocyte. This occurs in the process of human reproduction and marks the beginning of a new genetic identity, containing 46 chromosomes - 23 from the sperm and 23 from the egg. The zygote starts the journey of cell division and growth, eventually developing into a blastocyst, then an embryo, and finally a fetus over the course of pregnancy.

Ultrasonography, also known as sonography, is a diagnostic medical procedure that uses high-frequency sound waves (ultrasound) to produce dynamic images of organs, tissues, or blood flow inside the body. These images are captured in real-time and can be used to assess the size, shape, and structure of various internal structures, as well as detect any abnormalities such as tumors, cysts, or inflammation.

During an ultrasonography procedure, a small handheld device called a transducer is placed on the patient's skin, which emits and receives sound waves. The transducer sends high-frequency sound waves into the body, and these waves bounce back off internal structures and are recorded by the transducer. The recorded data is then processed and transformed into visual images that can be interpreted by a medical professional.

Ultrasonography is a non-invasive, painless, and safe procedure that does not use radiation like other imaging techniques such as CT scans or X-rays. It is commonly used to diagnose and monitor conditions in various parts of the body, including the abdomen, pelvis, heart, blood vessels, and musculoskeletal system.

Medical definitions of "Multiple Birth Offspring" refer to two or more children born to the same mother during one single pregnancy and childbirth. The most common forms of multiple birth offspring are twins (two babies), triplets (three babies), quadruplets (four babies), and so on.

The occurrence of multiple birth offspring is influenced by several factors, including genetics, maternal age, the use of fertility treatments, and other medical conditions. Multiple birth offspring may be identical (monozygotic) or fraternal (dizygotic), depending on whether they developed from a single fertilized egg or from separate eggs.

Multiple birth offspring often face unique health challenges, such as preterm birth, low birth weight, and developmental delays, due to the limited space and resources available in the womb. As a result, they may require specialized medical care and attention both during and after pregnancy.

"Freezing" is a term used in the medical field to describe a phenomenon that can occur in certain neurological conditions, most notably in Parkinson's disease. It refers to a sudden and temporary inability to move or initiate movement, often triggered by environmental factors such as narrow spaces, turning, or approaching a destination. This can increase the risk of falls and make daily activities challenging for affected individuals.

Freezing is also known as "freezing of gait" (FOG) when it specifically affects a person's ability to walk. During FOG episodes, the person may feel like their feet are glued to the ground, making it difficult to take steps forward. This can be very distressing and debilitating for those affected.

It is important to note that "freezing" has different meanings in different medical contexts, such as in the field of orthopedics, where it may refer to a loss of joint motion due to stiffness or inflammation. Always consult with a healthcare professional for accurate information tailored to your specific situation.

Monozygotic twinning, also known as identical twinning, is a type of twin pregnancy that occurs when a single fertilized egg (ovum) splits into two embryos during the early stages of development. This results in the formation of two genetically identical individuals who share the same set of DNA and are therefore considered to be genetic clones of each other.

Monozygotic twinning is thought to occur in about 1 in every 250 pregnancies, making it less common than dizygotic (fraternal) twinning, which occurs when two separate eggs are fertilized by two different sperm. In monozygotic twinning, the timing of the split determines the type of placenta and amniotic sac each twin will have.

If the split occurs within the first few days after fertilization, the twins will typically develop in separate amniotic sacs and have their own individual placentas. If the split occurs later, the twins may share an amniotic sac (monoamniotic) or a placenta (monochorionic), or both (monochorionic-monoamniotic).

Monozygotic twinning is associated with some increased risks for pregnancy complications, such as preterm labor and delivery, low birth weight, and twin-to-twin transfusion syndrome, a rare condition in which blood flows unevenly between the twins through shared placental blood vessels. However, most monozygotic twins are born healthy and develop normally.

The luteal phase is the second half of the menstrual cycle, starting from ovulation (release of an egg from the ovaries) and lasting until the start of the next menstruation. This phase typically lasts around 12-14 days in a regular 28-day menstrual cycle. During this phase, the remains of the dominant follicle that released the egg transform into the corpus luteum, which produces progesterone and some estrogen to support the implantation of a fertilized egg and maintain the early stages of pregnancy. If pregnancy does not occur, the corpus luteum degenerates, leading to a drop in hormone levels and the start of a new menstrual cycle.

Developmental gene expression regulation refers to the processes that control the activation or repression of specific genes during embryonic and fetal development. These regulatory mechanisms ensure that genes are expressed at the right time, in the right cells, and at appropriate levels to guide proper growth, differentiation, and morphogenesis of an organism.

Developmental gene expression regulation is a complex and dynamic process involving various molecular players, such as transcription factors, chromatin modifiers, non-coding RNAs, and signaling molecules. These regulators can interact with cis-regulatory elements, like enhancers and promoters, to fine-tune the spatiotemporal patterns of gene expression during development.

Dysregulation of developmental gene expression can lead to various congenital disorders and developmental abnormalities. Therefore, understanding the principles and mechanisms governing developmental gene expression regulation is crucial for uncovering the etiology of developmental diseases and devising potential therapeutic strategies.

Tubal pregnancy, also known as an ectopic pregnancy, is a type of pregnancy that occurs outside the uterus, usually in the fallopian tube. The fertilized egg implants and starts to develop in the tube instead of the uterine lining. This condition is not viable and can be life-threatening if not treated promptly.

The symptoms of a tubal pregnancy may include abdominal pain, vaginal bleeding, shoulder pain, dizziness or fainting, and pelvic discomfort or tenderness. If you suspect that you have a tubal pregnancy, it is important to seek medical attention immediately. Treatment options for tubal pregnancies include medication or surgery to remove the embryo and repair or remove the affected fallopian tube.

Spermatozoa are the male reproductive cells, or gametes, that are produced in the testes. They are microscopic, flagellated (tail-equipped) cells that are highly specialized for fertilization. A spermatozoon consists of a head, neck, and tail. The head contains the genetic material within the nucleus, covered by a cap-like structure called the acrosome which contains enzymes to help the sperm penetrate the female's egg (ovum). The long, thin tail propels the sperm forward through fluid, such as semen, enabling its journey towards the egg for fertilization.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted and released by the anterior pituitary gland. In females, it promotes the growth and development of ovarian follicles in the ovary, which ultimately leads to the maturation and release of an egg (ovulation). In males, FSH stimulates the testes to produce sperm. It works in conjunction with luteinizing hormone (LH) to regulate reproductive processes. The secretion of FSH is controlled by the hypothalamic-pituitary-gonadal axis and its release is influenced by the levels of gonadotropin-releasing hormone (GnRH), estrogen, inhibin, and androgens.

A surrogate mother is a woman who carries and gives birth to a child for another person or couple, called the intended parents. This can occur through traditional surrogacy, in which the surrogate mother is artificially inseminated with the intended father's sperm and she is genetically related to the child, or gestational surrogacy, in which the embryo created through in vitro fertilization (IVF) using the eggs and sperm of the intended parents or donors is transferred to the surrogate mother's uterus. Surrogacy arrangements are complex and involve legal, ethical, and emotional considerations. It is important for all parties involved to have a clear understanding of the process and to work with experienced professionals in order to ensure a successful outcome.

An incubator, in the context of medical care, is a device that creates and maintains an artificial environment for premature or sick newborn babies. The primary purpose of these devices is to provide a controlled setting that supports the infant's growth and development, especially when their underdeveloped bodies are not yet ready to maintain a stable temperature and other vital functions on their own.

Incubators typically include features such as:

1. Temperature control: They maintain a warm temperature, usually between 36.5°C (97.7°F) and 37.5°C (99.5°F), which is essential for the newborn's metabolism, growth, and overall health.
2. Humidity control: Incubators often have adjustable humidity levels to prevent the newborn from losing excess moisture through their delicate skin.
3. Oxygen supply: Some incubators come equipped with oxygen sensors and supplemental oxygen delivery systems to ensure the newborn receives adequate oxygenation.
4. Monitoring capabilities: Modern incubators often include built-in monitors that track various physiological parameters, such as heart rate, respiratory rate, and oxygen saturation, allowing healthcare professionals to closely monitor the infant's condition.
5. Lighting: Incubators may have adjustable lighting to provide a soothing environment for the newborn while also enabling medical staff to easily observe the infant.
6. Isolette: An isolette is a type of incubator that offers an enclosed, transparent structure with controlled temperature and humidity levels. It provides a protective space for the newborn while allowing caregivers easy access for handling and examining the infant.

Incubators play a crucial role in neonatal intensive care units (NICUs) by supporting premature or sick infants during their early stages of life, increasing their chances of survival and promoting healthy development.

Female fertility agents are medications or treatments that are used to enhance or restore female fertility. They can work in various ways such as stimulating ovulation, improving the quality of eggs, facilitating the implantation of a fertilized egg in the uterus, or addressing issues related to the reproductive system.

Some examples of female fertility agents include:

1. Clomiphene citrate (Clomid, Serophene): This medication stimulates ovulation by causing the pituitary gland to release more follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
2. Gonadotropins: These are hormonal medications that contain FSH and LH, which stimulate the ovaries to produce mature eggs. Examples include human menopausal gonadotropin (hMG) and follicle-stimulating hormone (FSH).
3. Letrozole (Femara): This medication is an aromatase inhibitor that can be used off-label to stimulate ovulation in women who do not respond to clomiphene citrate.
4. Metformin (Glucophage): This medication is primarily used to treat type 2 diabetes, but it can also improve fertility in women with polycystic ovary syndrome (PCOS) by regulating insulin levels and promoting ovulation.
5. Bromocriptine (Parlodel): This medication is used to treat infertility caused by hyperprolactinemia, a condition characterized by high levels of prolactin in the blood.
6. Assisted reproductive technologies (ART): These include procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). They involve manipulating eggs and sperm outside the body to facilitate fertilization and implantation.

It is important to consult with a healthcare provider or reproductive endocrinologist to determine the most appropriate fertility agent for individual needs, as these medications can have side effects and potential risks.

The Fallopian tubes, also known as uterine tubes or oviducts, are a pair of slender tubular structures in the female reproductive system. They play a crucial role in human reproduction by providing a passageway for the egg (ovum) from the ovary to the uterus (womb).

Each Fallopian tube is typically around 7.6 to 10 centimeters long and consists of four parts: the interstitial part, the isthmus, the ampulla, and the infundibulum. The fimbriated end of the infundibulum, which resembles a fringe or frill, surrounds and captures the released egg from the ovary during ovulation.

Fertilization usually occurs in the ampulla when sperm meets the egg after sexual intercourse. Once fertilized, the zygote (fertilized egg) travels through the Fallopian tube toward the uterus for implantation and further development. The cilia lining the inner surface of the Fallopian tubes help propel the egg and the zygote along their journey.

In some cases, abnormalities or blockages in the Fallopian tubes can lead to infertility or ectopic pregnancies, which are pregnancies that develop outside the uterus, typically within the Fallopian tube itself.

In medical terms, triplets are a type of multiple pregnancy, where three offsprings (fetuses) develop simultaneously in the uterus of a single pregnant woman. This occurs when a woman releases more than one egg during ovulation, and all three eggs get fertilized by separate sperm cells. Triplets can also occur through the use of assisted reproductive technologies such as in vitro fertilization (IVF) where multiple embryos are transferred into the uterus.

Triplet pregnancies carry a higher risk of complications for both the mother and the offsprings compared to singleton or twin pregnancies, including preterm labor, low birth weight, and developmental issues. As such, they often require close monitoring and specialized care throughout the pregnancy.

Follicular fluid is the fluid that accumulates within the follicle (a small sac or cyst) in the ovary where an egg matures. This fluid contains various chemicals, hormones, and proteins that support the growth and development of the egg cell. It also contains metabolic waste products and other substances from the granulosa cells (the cells that surround the egg cell within the follicle). Follicular fluid is often analyzed in fertility treatments and studies as it can provide valuable information about the health and viability of the egg cell.

An ovary is a part of the female reproductive system in which ova or eggs are produced through the process of oogenesis. They are a pair of solid, almond-shaped structures located one on each side of the uterus within the pelvic cavity. Each ovary measures about 3 to 5 centimeters in length and weighs around 14 grams.

The ovaries have two main functions: endocrine (hormonal) function and reproductive function. They produce and release eggs (ovulation) responsible for potential fertilization and development of an embryo/fetus during pregnancy. Additionally, they are essential in the production of female sex hormones, primarily estrogen and progesterone, which regulate menstrual cycles, sexual development, and reproduction.

During each menstrual cycle, a mature egg is released from one of the ovaries into the fallopian tube, where it may be fertilized by sperm. If not fertilized, the egg, along with the uterine lining, will be shed, leading to menstruation.

Microinjection is a medical technique that involves the use of a fine, precise needle to inject small amounts of liquid or chemicals into microscopic structures, cells, or tissues. This procedure is often used in research settings to introduce specific substances into individual cells for study purposes, such as introducing DNA or RNA into cell nuclei to manipulate gene expression.

In clinical settings, microinjections may be used in various medical and cosmetic procedures, including:

1. Intracytoplasmic Sperm Injection (ICSI): A type of assisted reproductive technology where a single sperm is injected directly into an egg to increase the chances of fertilization during in vitro fertilization (IVF) treatments.
2. Botulinum Toxin Injections: Microinjections of botulinum toxin (Botox, Dysport, or Xeomin) are used for cosmetic purposes to reduce wrinkles and fine lines by temporarily paralyzing the muscles responsible for their formation. They can also be used medically to treat various neuromuscular disorders, such as migraines, muscle spasticity, and excessive sweating (hyperhidrosis).
3. Drug Delivery: Microinjections may be used to deliver drugs directly into specific tissues or organs, bypassing the systemic circulation and potentially reducing side effects. This technique can be particularly useful in treating localized pain, delivering growth factors for tissue regeneration, or administering chemotherapy agents directly into tumors.
4. Gene Therapy: Microinjections of genetic material (DNA or RNA) can be used to introduce therapeutic genes into cells to treat various genetic disorders or diseases, such as cystic fibrosis, hemophilia, or cancer.

Overall, microinjection is a highly specialized and precise technique that allows for the targeted delivery of substances into small structures, cells, or tissues, with potential applications in research, medical diagnostics, and therapeutic interventions.

Gonadotropin-Releasing Hormone (GnRH), also known as Luteinizing Hormone-Releasing Hormone (LHRH), is a hormonal peptide consisting of 10 amino acids. It is produced and released by the hypothalamus, an area in the brain that links the nervous system to the endocrine system via the pituitary gland.

GnRH plays a crucial role in regulating reproduction and sexual development through its control of two gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These gonadotropins, in turn, stimulate the gonads (ovaries or testes) to produce sex steroids and eggs or sperm.

GnRH acts on the anterior pituitary gland by binding to its specific receptors, leading to the release of FSH and LH. The hypothalamic-pituitary-gonadal axis is under negative feedback control, meaning that when sex steroid levels are high, they inhibit the release of GnRH, which subsequently decreases FSH and LH secretion.

GnRH agonists and antagonists have clinical applications in various medical conditions, such as infertility treatments, precocious puberty, endometriosis, uterine fibroids, prostate cancer, and hormone-responsive breast cancer.

Micromanipulation is a term used in the field of medicine, specifically in assisted reproductive technologies (ARTs) such as in vitro fertilization (IVF). It refers to a technique that involves the manipulation of oocytes (human eggs), sperm, and/or embryos under a microscope using micromanipulative tools and equipment.

The most common form of micromanipulation is intracytoplasmic sperm injection (ICSI), where a single sperm is selected and injected directly into the cytoplasm of an oocyte to facilitate fertilization. Other forms of micromanipulation include assisted hatching (AH), where a small opening is made in the zona pellucida (the protective layer surrounding the embryo) to help the embryo hatch and implant into the uterus, and embryo biopsy, which involves removing one or more cells from an embryo for genetic testing.

Micromanipulation requires specialized training and equipment and is typically performed in IVF laboratories by experienced embryologists. The goal of micromanipulation is to improve the chances of successful fertilization, implantation, and pregnancy, particularly in cases where conventional methods have been unsuccessful or when there are specific fertility issues, such as male factor infertility or genetic disorders.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

"Animal pregnancy" is not a term that is typically used in medical definitions. However, in biological terms, animal pregnancy refers to the condition where a fertilized egg (or eggs) implants and develops inside the reproductive tract of a female animal, leading to the birth of offspring (live young).

The specific details of animal pregnancy can vary widely between different species, with some animals exhibiting phenomena such as placental development, gestation periods, and hormonal changes that are similar to human pregnancy, while others may have very different reproductive strategies.

It's worth noting that the study of animal pregnancy and reproduction is an important area of biological research, as it can provide insights into fundamental mechanisms of embryonic development, genetics, and evolution.

The first stage of labor is the period of time when the cervix dilates (opens) and effaces (thins out). This stage is further divided into two phases: the latent phase and the active phase. During the latent phase, the cervix begins to dilate and may progress slowly or stop and start. Contractions are often mild and irregular during this time. The active phase is characterized by more intense and regular contractions that cause the cervix to dilate more rapidly, typically at a rate of 1 cm per hour in first-time mothers.

The first stage of labor ends when the cervix is fully dilated (10 cm) and effaced, which signals the transition to the second stage of labor. During this stage, the mother begins pushing efforts to deliver the baby. It's important to note that the duration of each phase and the overall length of the first stage of labor can vary widely among individuals.

Nafarelin is a synthetic decapeptide analog of the natural gonadotropin-releasing hormone (GnRH). It is primarily used as a nasal spray for the treatment of central precocious puberty in children and endometriosis in adults.

In medical terms, Nafarelin is defined as:

A synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH) used in the treatment of central precocious puberty and endometriosis. It acts as a potent agonist of GnRH receptors, leading to an initial increase in the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), followed by downregulation of these receptors and a decrease in FSH and LH secretion. This results in decreased gonadal steroid production, including estrogen and testosterone, which helps to control the symptoms of central precocious puberty and endometriosis.

Nafarelin is available under the brand name Synarel and is administered as a nasal spray. It is important to note that Nafarelin can cause side effects such as hot flashes, headaches, and mood changes, and it may also affect bone growth in children with central precocious puberty. Therefore, it should be used under the close supervision of a healthcare provider.

Chorionic Gonadotropin, beta Subunit, Human (β-hCG) is a protein that is produced by the placenta during pregnancy. It is a component of human chorionic gonadotropin (hCG), which is a hormone that is composed of two subunits: alpha and beta. The β-hCG subunit is specific to hCG and is not found in other hormones, making it a useful marker for pregnancy and certain medical conditions.

During early pregnancy, the levels of β-hCG increase rapidly and can be detected in the blood and urine. This has led to the development of pregnancy tests that detect the presence of β-hCG to confirm pregnancy. In addition to its role in pregnancy, β-hCG is also used as a tumor marker for certain types of cancer, such as germ cell tumors and choriocarcinoma.

Elevated levels of β-hCG may indicate the presence of a molar pregnancy, a condition in which a fertilized egg implants in the uterus but does not develop properly. In some cases, a molar pregnancy can become cancerous and require treatment. Therefore, monitoring β-hCG levels during pregnancy is important for detecting any potential complications.

Litter size is a term used in veterinary medicine, particularly in relation to breeding of animals. It refers to the number of offspring that are born to an animal during one pregnancy. For example, in the case of dogs or cats, it would be the number of kittens or puppies born in a single litter. The size of the litter can vary widely depending on the species, breed, age, and health status of the parent animals.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

I. Definition:

An abortion in a veterinary context refers to the intentional or unintentional termination of pregnancy in a non-human animal before the fetus is capable of surviving outside of the uterus. This can occur spontaneously (known as a miscarriage) or be induced through medical intervention (induced abortion).

II. Common Causes:

Spontaneous abortions may result from genetic defects, hormonal imbalances, infections, exposure to toxins, trauma, or other maternal health issues. Induced abortions are typically performed for population control, humane reasons (such as preventing the birth of a severely deformed or non-viable fetus), or when the pregnancy poses a risk to the mother's health.

III. Methods:

Veterinarians may use various methods to induce abortion depending on the species, stage of gestation, and reason for the procedure. These can include administering drugs that stimulate uterine contractions (such as prostaglandins), physically removing the fetus through surgery (dilation and curettage or hysterectomy), or using techniques specific to certain animal species (e.g., intrauterine infusion of hypertonic saline in equids).

IV. Ethical Considerations:

The ethics surrounding veterinary abortions are complex and multifaceted, often involving considerations related to animal welfare, conservation, population management, and human-animal relationships. Veterinarians must weigh these factors carefully when deciding whether to perform an abortion and which method to use. In some cases, legal regulations may also influence the decision-making process.

V. Conclusion:

Abortion in veterinary medicine is a medical intervention that can be used to address various clinical scenarios, ranging from unintentional pregnancy loss to deliberate termination of pregnancy for humane or population control reasons. Ethical considerations play a significant role in the decision-making process surrounding veterinary abortions, and veterinarians must carefully evaluate each situation on a case-by-case basis.

Pregnancy maintenance refers to the ongoing process and care required to support and sustain a healthy pregnancy until childbirth. This includes regular prenatal check-ups to monitor the health of both the mother and the developing fetus, proper nutrition, regular exercise, and avoiding harmful behaviors such as smoking or consuming alcohol. In some cases, pregnancy maintenance may also include medical interventions such as hormone treatments or bed rest. The goal of pregnancy maintenance is to ensure the best possible outcome for both the mother and the baby.

Gamete Intrafallopian Transfer (GIFT) is a type of assisted reproductive technology (ART) that involves the transfer of both sperm and eggs directly into a woman's fallopian tubes through a surgical procedure. This process allows for fertilization to occur naturally within the woman's body, increasing the chances of successful implantation and pregnancy.

In GIFT, mature eggs are collected from the woman's ovaries through a minor surgical procedure called follicular aspiration. These eggs are then mixed with prepared sperm from the partner or a donor in the laboratory. The mixture of eggs and sperm is then transferred into the fallopian tubes using a thin catheter, which is inserted through a small incision made in the woman's abdomen.

GIFT is typically recommended for couples who have unexplained infertility or mild to moderate male factor infertility and for whom other fertility treatments, such as intrauterine insemination (IUI), have been unsuccessful. However, due to the invasive nature of the procedure and the need for general anesthesia, GIFT is less commonly used than other ART procedures, such as in vitro fertilization (IVF).

Fetal viability is the point in pregnancy at which a fetus is considered capable of surviving outside the uterus, given appropriate medical support. Although there is no precise gestational age that defines fetal viability, it is generally considered to occur between 24 and 28 weeks of gestation. At this stage, the fetus has developed sufficient lung maturity and body weight, and the risk of neonatal mortality and morbidity significantly decreases. However, the exact definition of fetal viability may vary depending on regional standards, medical facilities, and individual clinical assessments.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

A uterine contraction is a rhythmic, involuntary muscle tightening that occurs in the uterus. These contractions are primarily caused by the activation of smooth muscle cells within the uterine wall, known as myometrial cells. They play a crucial role in various reproductive processes, including menstruation, implantation of a fertilized egg, and childbirth (labor).

During labor, strong and frequent uterine contractions help to dilate the cervix and efface (thin) the lower part of the uterus. As the contractions become more intense and regular, they assist in moving the baby down through the birth canal, ultimately resulting in delivery. Uterine contractions are regulated by a complex interplay of hormones, neurotransmitters, and other signaling molecules, ensuring proper coordination and timing throughout the reproductive process.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

A pregnancy test is a medical diagnostic tool used to determine whether or not a woman is pregnant. These tests detect the presence of human chorionic gonadotropin (hCG), a hormone produced by the placenta after fertilization. Pregnancy tests can be performed using a variety of methods, including urine tests and blood tests.

Urine pregnancy tests are typically performed at home and involve either dipping a test strip into a sample of urine or holding the strip under a stream of urine for several seconds. The test strip contains antibodies that react with hCG, producing a visual signal such as a line or plus sign if hCG is present.

Blood pregnancy tests are performed by a healthcare provider and can detect lower levels of hCG than urine tests. There are two types of blood pregnancy tests: qualitative and quantitative. Qualitative tests simply detect the presence or absence of hCG, while quantitative tests measure the exact amount of hCG present in the blood.

Pregnancy tests are generally very accurate when used correctly, but false positives and false negatives can occur. False positives may occur due to certain medical conditions or medications that contain hCG. False negatives may occur if the test is taken too early or if it is not performed correctly. It is important to follow the instructions carefully and consult with a healthcare provider if there is any uncertainty about the results.

Monozygotic twins, also known as identical twins, are derived from a single fertilized egg (ovum) that splits and develops into two separate embryos. This results in the formation of genetically identical individuals who share the same genetic material, with the exception of potential mutations that may occur after the split. Monozygotic twins have the same sex, blood type, and other genetic traits. They are a unique pair of siblings, sharing an extraordinary degree of resemblance in physical characteristics, abilities, and behaviors.

Male infertility is a condition characterized by the inability to cause pregnancy in a fertile female. It is typically defined as the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse.

The causes of male infertility can be varied and include issues with sperm production, such as low sperm count or poor sperm quality, problems with sperm delivery, such as obstructions in the reproductive tract, or hormonal imbalances that affect sperm production. Other factors that may contribute to male infertility include genetic disorders, environmental exposures, lifestyle choices, and certain medical conditions or treatments.

It is important to note that male infertility can often be treated or managed with medical interventions, such as medication, surgery, or assisted reproductive technologies (ART). A healthcare provider can help diagnose the underlying cause of male infertility and recommend appropriate treatment options.

Triptorelin pamoate is a synthetic analogue of the natural hormone gonadotropin-releasing hormone (GnRH). It is used in the treatment of various conditions such as endometriosis, uterine fibroids, precocious puberty, and prostate cancer.

Triptorelin pamoate works by stimulating the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn stimulate the production of sex hormones such as estrogen and testosterone. However, with continued use, it causes downregulation of the pituitary gland, leading to a decrease in the production of FSH and LH, and therefore a reduction in the levels of sex hormones.

The pamoate salt is used to slow down the release of triptorelin, allowing for longer-acting formulations that can be administered monthly or quarterly. The medication is usually given as an injection into a muscle (intramuscularly).

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted by the anterior pituitary gland. In humans, FSH plays a crucial role in the reproductive system. Specifically, in females, it stimulates the growth of ovarian follicles in the ovary and the production of estrogen. In males, FSH promotes the formation of sperm within the testes' seminiferous tubules. The human FSH is a heterodimer, consisting of two noncovalently associated subunits: α (alpha) and β (beta). The alpha subunit is common to several pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). In contrast, the beta subunit is unique to FSH and determines its biological specificity. The regulation of FSH secretion is primarily controlled by the hypothalamic-pituitary axis, involving complex feedback mechanisms with gonadal steroid hormones and inhibins.

Tissue and organ harvesting is the surgical removal of healthy tissues or organs from a living or deceased donor for the purpose of transplantation into another person in need of a transplant. This procedure is performed with great care, adhering to strict medical standards and ethical guidelines, to ensure the safety and well-being of both the donor and the recipient.

In the case of living donors, the harvested tissue or organ is typically removed from a site that can be safely spared, such as a kidney, a portion of the liver, or a segment of the lung. The donor must undergo extensive medical evaluation to ensure they are physically and psychologically suitable for the procedure.

For deceased donors, tissue and organ harvesting is performed in a manner that respects their wishes and those of their family, as well as adheres to legal and ethical requirements. Organs and tissues must be recovered promptly after death to maintain their viability for transplantation.

Tissue and organ harvesting is an essential component of the transplant process, allowing individuals with terminal illnesses or severe injuries to receive life-saving or life-enhancing treatments. It is a complex and highly regulated medical practice that requires specialized training, expertise, and coordination among healthcare professionals, donor families, and recipients.

Ovulation is the medical term for the release of a mature egg from an ovary during a woman's menstrual cycle. The released egg travels through the fallopian tube where it may be fertilized by sperm if sexual intercourse has occurred recently. If the egg is not fertilized, it will break down and leave the body along with the uterine lining during menstruation. Ovulation typically occurs around day 14 of a 28-day menstrual cycle, but the timing can vary widely from woman to woman and even from cycle to cycle in the same woman.

During ovulation, there are several physical changes that may occur in a woman's body, such as an increase in basal body temperature, changes in cervical mucus, and mild cramping or discomfort on one side of the lower abdomen (known as mittelschmerz). These symptoms can be used to help predict ovulation and improve the chances of conception.

It's worth noting that some medical conditions, such as polycystic ovary syndrome (PCOS) or premature ovarian failure, may affect ovulation and make it difficult for a woman to become pregnant. In these cases, medical intervention may be necessary to help promote ovulation and increase the chances of conception.

An ovarian follicle is a fluid-filled sac in the ovary that contains an immature egg or ovum (oocyte). It's a part of the female reproductive system and plays a crucial role in the process of ovulation.

Ovarian follicles start developing in the ovaries during fetal development, but only a small number of them will mature and release an egg during a woman's reproductive years. The maturation process is stimulated by hormones like follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

There are different types of ovarian follicles, including primordial, primary, secondary, and tertiary or Graafian follicles. The Graafian follicle is the mature follicle that ruptures during ovulation to release the egg into the fallopian tube, where it may be fertilized by sperm.

It's important to note that abnormal growth or development of ovarian follicles can lead to conditions like polycystic ovary syndrome (PCOS) and ovarian cancer.

Embryo disposition is the term used to describe the process of determining what will be done with embryos that were created through in vitro fertilization (IVF) and are no longer needed or wanted by the individuals who produced them. This can include options such as donating them to other couples or individuals who are trying to conceive, donating them for research purposes, storing them for potential future use, or discarding them. The decision about embryo disposition is often a complex and emotional one, and it may involve ethical, legal, and religious considerations. It is typically made by the individuals who produced the embryos, in consultation with their healthcare provider and/or a mental health professional. In some cases, courts or other legal authorities may become involved in the decision-making process.

Fetal death, also known as stillbirth or intrauterine fetal demise, is defined as the death of a fetus at 20 weeks of gestation or later. The criteria for defining fetal death may vary slightly by country and jurisdiction, but in general, it refers to the loss of a pregnancy after the point at which the fetus is considered viable outside the womb.

Fetal death can occur for a variety of reasons, including chromosomal abnormalities, placental problems, maternal health conditions, infections, and umbilical cord accidents. In some cases, the cause of fetal death may remain unknown.

The diagnosis of fetal death is typically made through ultrasound or other imaging tests, which can confirm the absence of a heartbeat or movement in the fetus. Once fetal death has been diagnosed, medical professionals will work with the parents to determine the best course of action for managing the pregnancy and delivering the fetus. This may involve waiting for labor to begin naturally, inducing labor, or performing a cesarean delivery.

Experiencing a fetal death can be a very difficult and emotional experience for parents, and it is important for them to receive supportive care from their healthcare providers, family members, and friends. Grief counseling and support groups may also be helpful in coping with the loss.

ICR (Institute of Cancer Research) is a strain of albino Swiss mice that are widely used in scientific research. They are an outbred strain, which means that they have been bred to maintain maximum genetic heterogeneity. However, it is also possible to find inbred strains of ICR mice, which are genetically identical individuals produced by many generations of brother-sister mating.

Inbred ICR mice are a specific type of ICR mouse that has been inbred for at least 20 generations. This means that they have a high degree of genetic uniformity and are essentially genetically identical to one another. Inbred strains of mice are often used in research because their genetic consistency makes them more reliable models for studying biological phenomena and testing new therapies or treatments.

It is important to note that while inbred ICR mice may be useful for certain types of research, they do not necessarily represent the genetic diversity found in human populations. Therefore, it is important to consider the limitations of using any animal model when interpreting research findings and applying them to human health.

Fluorescence Resonance Energy Transfer (FRET) is not strictly a medical term, but it is a fundamental concept in biophysical and molecular biology research, which can have medical applications. Here's the definition of FRET:

Fluorescence Resonance Energy Transfer (FRET) is a distance-dependent energy transfer process between two fluorophores, often referred to as a donor and an acceptor. The process occurs when the emission spectrum of the donor fluorophore overlaps with the excitation spectrum of the acceptor fluorophore. When the donor fluorophore is excited, it can transfer its energy to the acceptor fluorophore through non-radiative dipole-dipole coupling, resulting in the emission of light from the acceptor at a longer wavelength than that of the donor.

FRET efficiency depends on several factors, including the distance between the two fluorophores, their relative orientation, and the spectral overlap between their excitation and emission spectra. FRET is typically efficient when the distance between the donor and acceptor is less than 10 nm (nanometers), making it a powerful tool for measuring molecular interactions, conformational changes, and distances at the molecular level.

In medical research, FRET has been used to study various biological processes, such as protein-protein interactions, enzyme kinetics, and gene regulation. It can also be used in developing biosensors for detecting specific molecules or analytes in clinical samples, such as blood or tissue.

Intravaginal administration refers to the delivery of medications or other substances directly into the vagina. This route of administration can be used for local treatment of vaginal infections or inflammation, or to deliver systemic medication that is absorbed through the vaginal mucosa.

Medications can be administered intravaginally using a variety of dosage forms, including creams, gels, foams, suppositories, and films. The choice of dosage form depends on several factors, such as the drug's physicochemical properties, the desired duration of action, and patient preference.

Intravaginal administration offers several advantages over other routes of administration. It allows for direct delivery of medication to the site of action, which can result in higher local concentrations and fewer systemic side effects. Additionally, some medications may be more effective when administered intravaginally due to their ability to bypass first-pass metabolism in the liver.

However, there are also potential disadvantages to intravaginal administration. Some women may find it uncomfortable or inconvenient to use this route of administration, and there is a risk of leakage or expulsion of the medication. Additionally, certain medications may cause local irritation or allergic reactions when administered intravaginally.

Overall, intravaginal administration can be a useful route of administration for certain medications and conditions, but it is important to consider the potential benefits and risks when choosing this method.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

A zebrafish is a freshwater fish species belonging to the family Cyprinidae and the genus Danio. Its name is derived from its distinctive striped pattern that resembles a zebra's. Zebrafish are often used as model organisms in scientific research, particularly in developmental biology, genetics, and toxicology studies. They have a high fecundity rate, transparent embryos, and a rapid development process, making them an ideal choice for researchers. However, it is important to note that providing a medical definition for zebrafish may not be entirely accurate or relevant since they are primarily used in biological research rather than clinical medicine.

Gestational age is the length of time that has passed since the first day of the last menstrual period (LMP) in pregnant women. It is the standard unit used to estimate the age of a pregnancy and is typically expressed in weeks. This measure is used because the exact date of conception is often not known, but the start of the last menstrual period is usually easier to recall.

It's important to note that since ovulation typically occurs around two weeks after the start of the LMP, gestational age is approximately two weeks longer than fetal age, which is the actual time elapsed since conception. Medical professionals use both gestational and fetal age to track the development and growth of the fetus during pregnancy.

The cervix is the lower, narrow part of the uterus that opens into the vagina. Cervical mucus is a clear or cloudy secretion produced by glands in the cervix. The amount and consistency of cervical mucus changes throughout a woman's menstrual cycle, influenced by hormonal fluctuations.

During the fertile window (approximately mid-cycle), estrogen levels rise, causing the cervical mucus to become more abundant, clear, and stretchy (often described as resembling raw egg whites). This "fertile" mucus facilitates the movement of sperm through the cervix and into the uterus, increasing the chances of fertilization.

As the menstrual cycle progresses and progesterone levels rise after ovulation, cervical mucus becomes thicker, cloudier, and less abundant, making it more difficult for sperm to penetrate. This change in cervical mucus helps prevent additional sperm from entering and fertilizing an already-fertilized egg.

Changes in cervical mucus can be used as a method of natural family planning or fertility awareness, with women checking their cervical mucus daily to identify their most fertile days. However, this method should be combined with other tracking methods for increased accuracy and reliability.

Clomiphene is a medication that is primarily used to treat infertility in women. It is an ovulatory stimulant, which means that it works by stimulating the development and release of mature eggs from the ovaries (a process known as ovulation). Clomiphene is a selective estrogen receptor modulator (SERM), which means that it binds to estrogen receptors in the body and blocks the effects of estrogen in certain tissues, while enhancing the effects of estrogen in others.

In the ovary, clomiphene works by blocking the negative feedback effect of estrogen on the hypothalamus and pituitary gland, which results in an increase in the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones stimulate the growth and development of ovarian follicles, which contain eggs. As the follicles grow and mature, they produce increasing amounts of estrogen, which eventually triggers a surge in LH that leads to ovulation.

Clomiphene is typically taken orally for 5 days, starting on the 3rd, 4th, or 5th day of the menstrual cycle. The dosage may be adjusted based on the patient's response to treatment. Common side effects of clomiphene include hot flashes, mood changes, breast tenderness, and ovarian hyperstimulation syndrome (OHSS), which is a potentially serious complication characterized by the enlargement of the ovaries and the accumulation of fluid in the abdomen.

It's important to note that clomiphene may not be suitable for everyone, and its use should be carefully monitored by a healthcare provider. Women with certain medical conditions, such as liver disease, thyroid disorders, or uterine fibroids, may not be able to take clomiphene. Additionally, women who become pregnant while taking clomiphene have an increased risk of multiple pregnancies (e.g., twins or triplets), which can pose additional risks to both the mother and the fetuses.

The cervix uteri, often simply referred to as the cervix, is the lower part of the uterus (womb) that connects to the vagina. It has an opening called the external os through which menstrual blood exits the uterus and sperm enters during sexual intercourse. During childbirth, the cervix dilates or opens to allow for the passage of the baby through the birth canal.

Quintuplets are defined in medical terms as a rare type of multiple pregnancy where a woman gives birth to five offspring at once. This occurs when one fertilized egg divides into five embryos, a phenomenon known as monozygotic quintuplets. Each baby shares the same genetic material and may be of the same sex. Quintuplets have a higher risk of preterm birth and other complications compared to singleton pregnancies. The survival rate for quintuplets has improved significantly over time due to advancements in medical technology and neonatal care.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

Adoptive transfer is a medical procedure in which immune cells are transferred from a donor to a recipient with the aim of providing immunity or treating a disease, such as cancer. This technique is often used in the field of immunotherapy and involves isolating specific immune cells (like T-cells) from the donor, expanding their numbers in the laboratory, and then infusing them into the patient. The transferred cells are expected to recognize and attack the target cells, such as malignant or infected cells, leading to a therapeutic effect. This process requires careful matching of donor and recipient to minimize the risk of rejection and graft-versus-host disease.

Cryoprotective agents are substances that are used to protect biological material from damage during freezing and thawing. These agents work by reducing the amount of ice that forms in the cells, which can help to prevent the formation of damaging ice crystals. Commonly used cryoprotective agents include dimethyl sulfoxide (DMSO), glycerol, and ethylene glycol.

When biological material, such as cells or tissues, is cooled to very low temperatures for storage or transportation, the water in the cells can freeze and form ice crystals. These ice crystals can damage the cell membranes and other structures within the cell, leading to cell death. Cryoprotective agents help to prevent this by lowering the freezing point of the solution that the cells are stored in, which reduces the amount of ice that forms.

Cryoprotective agents are often used in the field of assisted reproductive technology (ART) to protect sperm, eggs, and embryos during freezing and thawing. They are also used in research settings to preserve cells and tissues for later use. It is important to note that while cryoprotective agents can help to reduce the amount of damage that occurs during freezing and thawing, they cannot completely prevent it. Therefore, it is important to carefully control the freezing and thawing process to minimize any potential harm to the biological material.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis, the process by which cells create proteins. In protein synthesis, tRNAs serve as adaptors, translating the genetic code present in messenger RNA (mRNA) into the corresponding amino acids required to build a protein.

Each tRNA molecule has a distinct structure, consisting of approximately 70-90 nucleotides arranged in a cloverleaf shape with several loops and stems. The most important feature of a tRNA is its anticodon, a sequence of three nucleotides located in one of the loops. This anticodon base-pairs with a complementary codon on the mRNA during translation, ensuring that the correct amino acid is added to the growing polypeptide chain.

Before tRNAs can participate in protein synthesis, they must be charged with their specific amino acids through an enzymatic process involving aminoacyl-tRNA synthetases. These enzymes recognize and bind to both the tRNA and its corresponding amino acid, forming a covalent bond between them. Once charged, the aminoacyl-tRNA complex is ready to engage in translation and contribute to protein formation.

In summary, transfer RNA (tRNA) is a small RNA molecule that facilitates protein synthesis by translating genetic information from messenger RNA into specific amino acids, ultimately leading to the creation of functional proteins within cells.

A gastrula is a stage in the early development of many animals, including humans, that occurs following fertilization and cleavage of the zygote. During this stage, the embryo undergoes a process called gastrulation, which involves a series of cell movements that reorganize the embryo into three distinct layers: the ectoderm, mesoderm, and endoderm. These germ layers give rise to all the different tissues and organs in the developing organism.

The gastrula is characterized by the presence of a central cavity called the archenteron, which will eventually become the gut or gastrointestinal tract. The opening of the archenteron is called the blastopore, which will give rise to either the mouth or anus, depending on the animal group.

In summary, a gastrula is a developmental stage in which an embryo undergoes gastrulation to form three germ layers and a central cavity, which will eventually develop into various organs and tissues of the body.

Quadruplets are defined in medicine as a type of multiple birth where four offspring are produced from the same pregnancy. This occurs when a single fertilized egg divides into four embryos, or more rarely, when four separate eggs are each fertilized by different sperm. Quadruplets face higher risks of preterm birth and other complications compared to singleton pregnancies.

In medical terms, suction refers to the process of creating and maintaining a partial vacuum in order to remove fluids or gases from a body cavity or wound. This is typically accomplished using specialized medical equipment such as a suction machine, which uses a pump to create the vacuum, and a variety of different suction tips or catheters that can be inserted into the area being treated.

Suction is used in a wide range of medical procedures and treatments, including wound care, surgical procedures, respiratory therapy, and diagnostic tests. It can help to remove excess fluids such as blood or pus from a wound, clear secretions from the airways during mechanical ventilation, or provide a means of visualizing internal structures during endoscopic procedures.

It is important to use proper technique when performing suctioning, as excessive or improperly applied suction can cause tissue damage or bleeding. Medical professionals are trained in the safe and effective use of suction equipment and techniques to minimize risks and ensure optimal patient outcomes.

Birth weight refers to the first weight of a newborn infant, usually taken immediately after birth. It is a critical vital sign that indicates the baby's health status and is used as a predictor for various short-term and long-term health outcomes.

Typically, a full-term newborn's weight ranges from 5.5 to 8.8 pounds (2.5 to 4 kg), although normal birth weights can vary significantly based on factors such as gestational age, genetics, maternal health, and nutrition. Low birth weight is defined as less than 5.5 pounds (2.5 kg), while high birth weight is greater than 8.8 pounds (4 kg).

Low birth weight babies are at a higher risk for various medical complications, including respiratory distress syndrome, jaundice, infections, and developmental delays. High birth weight babies may face challenges with delivery, increased risk of obesity, and potential metabolic issues later in life. Regular prenatal care is essential to monitor fetal growth and ensure a healthy pregnancy and optimal birth weight for the baby.

"Body patterning" is a general term that refers to the process of forming and organizing various tissues and structures into specific patterns during embryonic development. This complex process involves a variety of molecular mechanisms, including gene expression, cell signaling, and cell-cell interactions. It results in the creation of distinct body regions, such as the head, trunk, and limbs, as well as the organization of internal organs and systems.

In medical terminology, "body patterning" may refer to specific developmental processes or abnormalities related to embryonic development. For example, in genetic disorders such as Poland syndrome or Holt-Oram syndrome, mutations in certain genes can lead to abnormal body patterning, resulting in the absence or underdevelopment of certain muscles, bones, or other structures.

It's important to note that "body patterning" is not a formal medical term with a specific definition, but rather a general concept used in developmental biology and genetics.

The follicular phase is a term used in reproductive endocrinology, which refers to the first part of the menstrual cycle. This phase begins on the first day of menstruation and lasts until ovulation. During this phase, several follicles in the ovaries begin to mature under the influence of follicle-stimulating hormone (FSH) released by the pituitary gland.

Typically, one follicle becomes dominant and continues to mature, while the others regress. The dominant follicle produces increasing amounts of estrogen, which causes the lining of the uterus to thicken in preparation for a possible pregnancy. The follicular phase can vary in length, but on average it lasts about 14 days.

It's important to note that the length and characteristics of the follicular phase can provide valuable information in diagnosing various reproductive disorders, such as polycystic ovary syndrome (PCOS) or thyroid dysfunction.

A "patient transfer" is a medical procedure that involves moving a patient from one location, piece of medical equipment, or healthcare provider to another. This can include:

1. Transferring a patient from a bed to a stretcher, wheelchair, or other mobility device.
2. Moving a patient from a hospital bed to a surgical table or imaging machine such as an MRI or CT scanner.
3. Transporting a patient between healthcare facilities, such as from a hospital to a rehabilitation center or long-term care facility.
4. Transferring a patient between medical teams during the course of their treatment, like when they are moved from the emergency department to the intensive care unit.

Patient transfers require careful planning and execution to ensure the safety and comfort of the patient, as well as to prevent any potential injuries or complications for both the patient and the healthcare providers involved in the process. Proper techniques, equipment, and communication are essential for a successful patient transfer.

In situ hybridization (ISH) is a molecular biology technique used to detect and localize specific nucleic acid sequences, such as DNA or RNA, within cells or tissues. This technique involves the use of a labeled probe that is complementary to the target nucleic acid sequence. The probe can be labeled with various types of markers, including radioisotopes, fluorescent dyes, or enzymes.

During the ISH procedure, the labeled probe is hybridized to the target nucleic acid sequence in situ, meaning that the hybridization occurs within the intact cells or tissues. After washing away unbound probe, the location of the labeled probe can be visualized using various methods depending on the type of label used.

In situ hybridization has a wide range of applications in both research and diagnostic settings, including the detection of gene expression patterns, identification of viral infections, and diagnosis of genetic disorders.

Sex determination analysis is a medical or biological examination used to establish the genetic or phenotypic sex of an individual. This can be done through various methods, including:

1. Genetic testing: Examination of an individual's DNA to identify the presence of specific sex chromosomes (XX for females and XY for males). This is typically performed through a blood or tissue sample.
2. Chromosomal analysis: Microscopic examination of an individual's chromosomes to determine their number and structure. In humans, females typically have 46 chromosomes, including two X chromosomes (46,XX), while males typically have 46 chromosomes, including one X and one Y chromosome (46,XY).
3. Phenotypic analysis: Observation of an individual's physical characteristics, such as the presence or absence of certain sex organs or secondary sexual characteristics, to determine their phenotypic sex.

Sex determination analysis is used in various medical and research contexts, including prenatal testing, diagnosis of disorders of sex development (DSDs), forensic investigations, and population studies. It's important to note that while sex determination analysis can provide information about an individual's genetic or phenotypic sex, it does not necessarily reflect their gender identity, which is a personal sense of being male, female, or something else.

Phospholipid transfer proteins (PLTPs) are a group of proteins found in the bloodstream that play a crucial role in the distribution and metabolism of phospholipids, which are key components of cell membranes. These proteins facilitate the transfer of phospholipids between different lipoprotein particles, such as high-density lipoproteins (HDL) and low-density lipoproteins (LDL), in a process known as non-vesicular lipid transport.

PLTPs can also modulate the size, composition, and function of these lipoprotein particles, which has implications for lipid metabolism, inflammation, and atherosclerosis. Additionally, PLTPs have been implicated in various physiological processes, including cell signaling, membrane trafficking, and host defense mechanisms.

It is worth noting that while PLTPs are important regulators of lipid metabolism, their precise role in human health and disease is still an area of active research.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Leuprolide is a synthetic hormonal analog of gonadotropin-releasing hormone (GnRH or LHRH). It acts as a potent agonist of GnRH receptors, leading to the suppression of pituitary gland's secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This, in turn, results in decreased levels of sex hormones such as testosterone and estrogen.

Leuprolide is used clinically for the treatment of various conditions related to hormonal imbalances, including:
- Prostate cancer: Leuprolide can help slow down the growth of prostate cancer cells by reducing testosterone levels in the body.
- Endometriosis: By lowering estrogen levels, leuprolide can alleviate symptoms associated with endometriosis such as pelvic pain and menstrual irregularities.
- Central precocious puberty: Leuprolide is used to delay the onset of puberty in children who experience it prematurely by inhibiting the release of gonadotropins.
- Uterine fibroids: Lowering estrogen levels with leuprolide can help shrink uterine fibroids and reduce symptoms like heavy menstrual bleeding and pelvic pain.

Leuprolide is available in various formulations, such as injectable depots or implants, for long-term hormonal suppression. Common side effects include hot flashes, mood changes, and potential loss of bone density due to prolonged hormone suppression.

"Delivery, Obstetric" is a medical term that refers to the process of giving birth to a baby. It involves the passage of the fetus through the mother's vagina or via Caesarean section (C-section), which is a surgical procedure.

The obstetric delivery process typically includes three stages:

1. The first stage begins with the onset of labor and ends when the cervix is fully dilated.
2. The second stage starts with full dilation of the cervix and ends with the birth of the baby.
3. The third stage involves the delivery of the placenta, which is the organ that provides oxygen and nutrients to the developing fetus during pregnancy.

Obstetric delivery requires careful monitoring and management by healthcare professionals to ensure the safety and well-being of both the mother and the baby. Various interventions and techniques may be used during the delivery process to facilitate a safe and successful outcome, including the use of medications, assisted delivery with forceps or vacuum extraction, and C-section.

Reproductive medicine is a branch of medicine that deals with the prevention, diagnosis, and management of reproductive health disorders, including infertility, sexual dysfunction, and other reproductive system-related issues. It involves a multidisciplinary approach, combining expertise from various medical specialties such as obstetrics, gynecology, endocrinology, urology, and genetics.

Reproductive medicine encompasses several areas of focus, including:

1. Infertility treatment: Utilizing assisted reproductive technologies (ART) like in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and other techniques to help individuals or couples conceive.
2. Contraception: Providing various methods for family planning, including hormonal contraceptives, barrier methods, and permanent sterilization procedures.
3. Sexual dysfunction: Addressing issues related to sexual desire, arousal, orgasm, and pain through medical interventions, counseling, or surgical treatments.
4. Reproductive endocrinology: Managing hormonal imbalances affecting reproductive health, such as polycystic ovary syndrome (PCOS), premature ovarian failure, and hypogonadism.
5. Genetic counseling and testing: Assessing the risk of inheritable genetic disorders and providing guidance on family planning options.
6. Menopause management: Offering treatments for symptoms associated with menopause, such as hot flashes, vaginal dryness, and mood changes.
7. Fertility preservation: Providing options for individuals facing cancer treatment or other medical conditions that may impact their future fertility, including egg, sperm, and embryo freezing.
8. Adolescent reproductive health: Addressing the unique needs of adolescents related to sexual and reproductive health, including education, counseling, and preventative care.
9. Andrology: Focusing on male reproductive health, including issues related to sperm production, function, and genital abnormalities.

Cumulus cells are a type of specialized cell that surround and support the egg (oocyte) in the ovary of female mammals, including humans. These cells are located in the cumulus oophorus, which is a cluster of cells that surrounds and protects the mature egg within the follicle.

Cumulus cells play an important role in the process of fertilization by providing nutrients to the developing egg and helping to regulate its growth and development. They also help to facilitate communication between the egg and the surrounding follicular cells, which is necessary for the release of the mature egg from the ovary during ovulation.

In addition to their role in reproduction, cumulus cells have been studied for their potential use in various medical applications, including as a source of stem cells for therapeutic purposes. However, more research is needed to fully understand the properties and potential uses of these cells.

Aneuploidy is a medical term that refers to an abnormal number of chromosomes in a cell. Chromosomes are thread-like structures located inside the nucleus of cells that contain genetic information in the form of genes.

In humans, the normal number of chromosomes in a cell is 46, arranged in 23 pairs. Aneuploidy occurs when there is an extra or missing chromosome in one or more of these pairs. For example, Down syndrome is a condition that results from an extra copy of chromosome 21, also known as trisomy 21.

Aneuploidy can arise during the formation of gametes (sperm or egg cells) due to errors in the process of cell division called meiosis. These errors can result in eggs or sperm with an abnormal number of chromosomes, which can then lead to aneuploidy in the resulting embryo.

Aneuploidy is a significant cause of birth defects and miscarriages. The severity of the condition depends on which chromosomes are affected and the extent of the abnormality. In some cases, aneuploidy may have no noticeable effects, while in others it can lead to serious health problems or developmental delays.

A genetic vector is a vehicle, often a plasmid or a virus, that is used to introduce foreign DNA into a host cell as part of genetic engineering or gene therapy techniques. The vector contains the desired gene or genes, along with regulatory elements such as promoters and enhancers, which are needed for the expression of the gene in the target cells.

The choice of vector depends on several factors, including the size of the DNA to be inserted, the type of cell to be targeted, and the efficiency of uptake and expression required. Commonly used vectors include plasmids, adenoviruses, retroviruses, and lentiviruses.

Plasmids are small circular DNA molecules that can replicate independently in bacteria. They are often used as cloning vectors to amplify and manipulate DNA fragments. Adenoviruses are double-stranded DNA viruses that infect a wide range of host cells, including human cells. They are commonly used as gene therapy vectors because they can efficiently transfer genes into both dividing and non-dividing cells.

Retroviruses and lentiviruses are RNA viruses that integrate their genetic material into the host cell's genome. This allows for stable expression of the transgene over time. Lentiviruses, a subclass of retroviruses, have the advantage of being able to infect non-dividing cells, making them useful for gene therapy applications in post-mitotic tissues such as neurons and muscle cells.

Overall, genetic vectors play a crucial role in modern molecular biology and medicine, enabling researchers to study gene function, develop new therapies, and modify organisms for various purposes.

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

In medical terms, "breeding" is not a term that is commonly used. It is more frequently used in the context of animal husbandry to refer to the process of mating animals in order to produce offspring with specific desired traits or characteristics. In human medicine, the term is not typically applied to people and instead, related concepts such as reproduction, conception, or pregnancy are used.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Morphogenesis is a term used in developmental biology and refers to the process by which cells give rise to tissues and organs with specific shapes, structures, and patterns during embryonic development. This process involves complex interactions between genes, cells, and the extracellular environment that result in the coordinated movement and differentiation of cells into specialized functional units.

Morphogenesis is a dynamic and highly regulated process that involves several mechanisms, including cell proliferation, death, migration, adhesion, and differentiation. These processes are controlled by genetic programs and signaling pathways that respond to environmental cues and regulate the behavior of individual cells within a developing tissue or organ.

The study of morphogenesis is important for understanding how complex biological structures form during development and how these processes can go awry in disease states such as cancer, birth defects, and degenerative disorders.

Pregnancy-specific beta-1 glycoproteins (PSBGs), also known as SP1 or SP-1, are a group of proteins that are produced in large quantities by the placenta during pregnancy. They were first discovered in 1974 and are found in the serum of pregnant women. These proteins belong to the immunoglobulin superfamily and are involved in various physiological processes during pregnancy, such as implantation, placentation, and fetal development.

PSBGs have been identified as potential markers for early pregnancy diagnosis, as their levels start to rise shortly after conception and can be detected in the maternal bloodstream within days of implantation. They also play a role in the regulation of immune responses during pregnancy, helping to prevent the mother's immune system from attacking the developing fetus.

There are several isoforms of PSBGs, including PSBG1, PSBG2, and PSBG3, which differ in their molecular weight and other biochemical properties. The function of these different isoforms is not fully understood, but they may have distinct roles in the regulation of pregnancy-related processes.

It's worth noting that while PSBGs are produced during pregnancy, they can also be found in non-pregnant individuals, albeit at much lower levels. The exact role of PSBGs outside of pregnancy is not well understood and requires further research.

Embryo research refers to the scientific study and experimentation that involves human embryos. This research is conducted in order to gain a better understanding of human development during the earliest stages of life, as well as to investigate potential treatments for various diseases and conditions.

Human embryos used in research are typically created through in vitro fertilization (IVF) procedures, in which sperm and eggs are combined in a laboratory dish to form an embryo. These embryos may be donated by individuals or couples who have undergone IVF treatments and have excess embryos that they do not plan to use for reproduction.

Embryo research can involve a variety of techniques, including stem cell research, genetic testing, and cloning. The goal of this research is to advance our knowledge of human development and disease, as well as to develop new treatments and therapies for a wide range of medical conditions. However, embryo research is a controversial topic, and there are ethical concerns surrounding the use of human embryos in scientific research.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Transfer factors are natural immune system components that are passed from one individual to another, usually through blood products. They are small proteins called cytokines that are secreted by certain white blood cells (T-lymphocytes or T-cells) and function to regulate the immune system's response to foreign substances.

Transfer factors can be extracted from human blood and given to individuals with weakened immune systems, such as those undergoing chemotherapy or suffering from immune deficiency disorders, to help enhance their immune response. They have also been used in the treatment of chronic fatigue syndrome, allergies, and certain viral infections.

It's important to note that while transfer factors have shown promise in some studies, more research is needed to fully understand their effectiveness and safety.

Luteolytic agents are substances that cause the breakdown or regression of the corpus luteum, a temporary endocrine structure in the ovary that forms after ovulation and produces progesterone during early pregnancy in mammals. These agents work by inhibiting the secretion of prostaglandins, which are necessary for maintaining the integrity of the corpus luteum. By causing the breakdown of the corpus luteum, luteolytic agents can induce menstruation or cause the termination of an early pregnancy. Examples of luteolytic agents include prostaglandin F2alpha (PGF2α) and its analogs, as well as certain dopamine agonists such as cabergoline. These agents are used in various clinical settings, including reproductive medicine and veterinary medicine.

Oligospermia is a medical term used to describe a condition in which the semen contains a lower than normal number of sperm. Generally, a sperm count of less than 15 million sperm per milliliter (ml) of semen is considered to be below the normal range.

Oligospermia can make it more difficult for a couple to conceive naturally and may require medical intervention such as intracytoplasmic sperm injection (ICSI) or in vitro fertilization (IVF). The condition can result from various factors, including hormonal imbalances, genetic abnormalities, varicocele, environmental factors, and certain medications.

It's important to note that oligospermia is not the same as azoospermia, which is a condition where there is no sperm present in the semen at all.

High-risk pregnancy is a term used to describe a situation where the mother or the fetus has an increased risk of developing complications during pregnancy, labor, delivery, or in the postpartum period. These risks may be due to pre-existing medical conditions in the mother, such as diabetes, hypertension, heart disease, kidney disease, autoimmune disorders, or infectious diseases like HIV/AIDS. Other factors that can contribute to a high-risk pregnancy include advanced maternal age (35 years and older), obesity, multiple gestations (twins, triplets, etc.), fetal growth restriction, placental issues, and a history of previous pregnancy complications or preterm labor.

High-risk pregnancies require specialized care and monitoring by healthcare professionals, often involving maternal-fetal medicine specialists, obstetricians, perinatologists, and neonatologists. Regular prenatal care, frequent checkups, ultrasound monitoring, and sometimes additional testing and interventions may be necessary to ensure the best possible outcomes for both the mother and the baby.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Ectogenesis is a theoretical concept in medical and reproductive biology that refers to the development of an organism outside of the body, typically referring to the growth and development of a fetus or embryo in an artificial environment, such as an external womb or an artificial uterus. This concept is still largely speculative and not currently possible with existing technology. It raises various ethical, legal, and social questions related to pregnancy, reproduction, and the nature of parenthood.

In medical and embryological terms, the mesoderm is one of the three primary germ layers in the very early stages of embryonic development. It forms between the ectoderm and endoderm during gastrulation, and it gives rise to a wide variety of cell types, tissues, and organs in the developing embryo.

The mesoderm contributes to the formation of structures such as:

1. The connective tissues (including tendons, ligaments, and most of the bones)
2. Muscular system (skeletal, smooth, and cardiac muscles)
3. Circulatory system (heart, blood vessels, and blood cells)
4. Excretory system (kidneys and associated structures)
5. Reproductive system (gonads, including ovaries and testes)
6. Dermis of the skin
7. Parts of the eye and inner ear
8. Several organs in the urogenital system

Dysfunctions or abnormalities in mesoderm development can lead to various congenital disorders and birth defects, highlighting its importance during embryogenesis.

Relaxin is a hormone produced by the ovaries and, during pregnancy, also by the placenta and the fetal membranes. Its primary function is to relax the uterus and pelvic joints in preparation for childbirth, hence its name. It does this by softening the connective tissues and increasing their elasticity, which allows them to stretch more easily. Relaxin also plays a role in the cardiovascular system during pregnancy, helping to maintain healthy blood pressure levels.

Additionally, relaxin has been shown to have effects on other parts of the body, such as reducing muscle stiffness and joint pain, increasing flexibility, and potentially even playing a role in bone metabolism. However, more research is needed to fully understand all of its functions and potential therapeutic uses.

Gonadotropins are hormones that stimulate the gonads (sex glands) to produce sex steroids and gametes (sex cells). In humans, there are two main types of gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are produced and released by the anterior pituitary gland.

FSH plays a crucial role in the development and maturation of ovarian follicles in females and sperm production in males. LH triggers ovulation in females, causing the release of a mature egg from the ovary, and stimulates testosterone production in males.

Gonadotropins are often used in medical treatments to stimulate the gonads, such as in infertility therapies where FSH and LH are administered to induce ovulation or increase sperm production.

Genetic conjugation is a type of genetic transfer that occurs between bacterial cells. It involves the process of one bacterium (the donor) transferring a piece of its DNA to another bacterium (the recipient) through direct contact or via a bridge-like connection called a pilus. This transferred DNA may contain genes that provide the recipient cell with new traits, such as antibiotic resistance or virulence factors, which can make the bacteria more harmful or difficult to treat. Genetic conjugation is an important mechanism for the spread of antibiotic resistance and other traits among bacterial populations.

The placenta is an organ that develops in the uterus during pregnancy and provides oxygen and nutrients to the growing baby through the umbilical cord. It also removes waste products from the baby's blood. The placenta attaches to the wall of the uterus, and the baby's side of the placenta contains many tiny blood vessels that connect to the baby's circulatory system. This allows for the exchange of oxygen, nutrients, and waste between the mother's and baby's blood. After the baby is born, the placenta is usually expelled from the uterus in a process called afterbirth.

The vagina is the canal that joins the cervix (the lower part of the uterus) to the outside of the body. It also is known as the birth canal because babies pass through it during childbirth. The vagina is where sexual intercourse occurs and where menstrual blood exits the body. It has a flexible wall that can expand and retract. During sexual arousal, the vaginal walls swell with blood to become more elastic in order to accommodate penetration.

It's important to note that sometimes people use the term "vagina" to refer to the entire female genital area, including the external structures like the labia and clitoris. But technically, these are considered part of the vulva, not the vagina.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

The myometrium is the middle and thickest layer of the uterine wall, composed mainly of smooth muscle cells. It is responsible for the strong contractions during labor and can also contribute to bleeding during menstruation or childbirth. The myometrium is able to stretch and expand to accommodate a growing fetus and then contract during labor to help push the baby out. It also plays a role in maintaining the structure and shape of the uterus, and in protecting the internal organs within the pelvic cavity.

Inbred strains of mice are defined as lines of mice that have been brother-sister mated for at least 20 consecutive generations. This results in a high degree of homozygosity, where the mice of an inbred strain are genetically identical to one another, with the exception of spontaneous mutations.

Inbred strains of mice are widely used in biomedical research due to their genetic uniformity and stability, which makes them useful for studying the genetic basis of various traits, diseases, and biological processes. They also provide a consistent and reproducible experimental system, as compared to outbred or genetically heterogeneous populations.

Some commonly used inbred strains of mice include C57BL/6J, BALB/cByJ, DBA/2J, and 129SvEv. Each strain has its own unique genetic background and phenotypic characteristics, which can influence the results of experiments. Therefore, it is important to choose the appropriate inbred strain for a given research question.

Ectoderm is the outermost of the three primary germ layers in a developing embryo, along with the endoderm and mesoderm. The ectoderm gives rise to the outer covering of the body, including the skin, hair, nails, glands, and the nervous system, which includes the brain, spinal cord, and peripheral nerves. It also forms the lining of the mouth, anus, nose, and ears. Essentially, the ectoderm is responsible for producing all the epidermal structures and the neural crest cells that contribute to various derivatives such as melanocytes, adrenal medulla, smooth muscle, and peripheral nervous system components.

Cholesteryl ester transfer proteins (CETP) are a group of plasma proteins that play a role in the transport and metabolism of lipids, particularly cholesteryl esters and triglycerides, between different lipoprotein particles in the bloodstream. These proteins facilitate the transfer of cholesteryl esters from high-density lipoproteins (HDL) to low-density lipoproteins (LDL) and very low-density lipoproteins (VLDL), while simultaneously promoting the transfer of triglycerides in the opposite direction, from VLDL and LDL to HDL.

The net effect of CETP activity is a decrease in HDL cholesterol levels and an increase in LDL and VLDL cholesterol levels. This shift in lipoprotein composition can contribute to the development of atherosclerosis and cardiovascular disease, as lower HDL cholesterol levels and higher LDL cholesterol levels are associated with increased risk for these conditions.

Inhibition of CETP has been investigated as a potential strategy for increasing HDL cholesterol levels and reducing the risk of cardiovascular disease. However, clinical trials with CETP inhibitors have shown mixed results, and further research is needed to determine their safety and efficacy in preventing cardiovascular events.

Fertility is the natural ability to conceive or to cause conception of offspring. In humans, it is the capacity of a woman and a man to reproduce through sexual reproduction. For women, fertility usually takes place during their reproductive years, which is from adolescence until menopause. A woman's fertility depends on various factors including her age, overall health, and the health of her reproductive system.

For men, fertility can be affected by a variety of factors such as age, genetics, general health, sexual function, and environmental factors that may affect sperm production or quality. Factors that can negatively impact male fertility include exposure to certain chemicals, radiation, smoking, alcohol consumption, drug use, and sexually transmitted infections (STIs).

Infertility is a common medical condition affecting about 10-15% of couples trying to conceive. Infertility can be primary or secondary. Primary infertility refers to the inability to conceive after one year of unprotected sexual intercourse, while secondary infertility refers to the inability to conceive following a previous pregnancy.

Infertility can be treated with various medical and surgical interventions depending on the underlying cause. These may include medications to stimulate ovulation, intrauterine insemination (IUI), in vitro fertilization (IVF), or surgery to correct anatomical abnormalities.

The Electron Transport Chain (ETC) is a series of complexes in the inner mitochondrial membrane that are involved in the process of cellular respiration. It is the final pathway for electrons derived from the oxidation of nutrients such as glucose, fatty acids, and amino acids to be transferred to molecular oxygen. This transfer of electrons drives the generation of a proton gradient across the inner mitochondrial membrane, which is then used by ATP synthase to produce ATP, the main energy currency of the cell.

The electron transport chain consists of four complexes (I-IV) and two mobile electron carriers (ubiquinone and cytochrome c). Electrons from NADH and FADH2 are transferred to Complex I and Complex II respectively, which then pass them along to ubiquinone. Ubiquinone then transfers the electrons to Complex III, which passes them on to cytochrome c. Finally, cytochrome c transfers the electrons to Complex IV, where they combine with oxygen and protons to form water.

The transfer of electrons through the ETC is accompanied by the pumping of protons from the mitochondrial matrix to the intermembrane space, creating a proton gradient. The flow of protons back across the inner membrane through ATP synthase drives the synthesis of ATP from ADP and inorganic phosphate.

Overall, the electron transport chain is a crucial process for generating energy in the form of ATP in the cell, and it plays a key role in many metabolic pathways.

Dilation, also known as dilatation, refers to the process of expanding or enlarging a body passage or cavity. In medical terms, it typically refers to the widening of a bodily opening or hollow organ, allowing for increased flow or access. This can occur naturally, such as during childbirth when the cervix dilates to allow for the passage of a baby, or it can be induced through medical procedures or interventions.

For example, dilation of the pupils is a natural response to darkness or certain medications, while dilation of blood vessels is a common side effect of some drugs and can also occur in response to changes in temperature or emotional state. Dilation of the stomach or intestines may be necessary for medical procedures such as endoscopies or surgeries.

It's important to note that dilation can also refer to the abnormal enlargement of a body part, such as dilated cardiomyopathy, which refers to an enlarged and weakened heart muscle.

Pregnancy complications refer to any health problems that arise during pregnancy which can put both the mother and the baby at risk. These complications may occur at any point during the pregnancy, from conception until childbirth. Some common pregnancy complications include:

1. Gestational diabetes: a type of diabetes that develops during pregnancy in women who did not have diabetes before becoming pregnant.
2. Preeclampsia: a pregnancy complication characterized by high blood pressure and damage to organs such as the liver or kidneys.
3. Placenta previa: a condition where the placenta covers the cervix, which can cause bleeding and may require delivery via cesarean section.
4. Preterm labor: when labor begins before 37 weeks of gestation, which can lead to premature birth and other complications.
5. Intrauterine growth restriction (IUGR): a condition where the fetus does not grow at a normal rate inside the womb.
6. Multiple pregnancies: carrying more than one baby, such as twins or triplets, which can increase the risk of premature labor and other complications.
7. Rh incompatibility: a condition where the mother's blood type is different from the baby's, which can cause anemia and jaundice in the newborn.
8. Pregnancy loss: including miscarriage, stillbirth, or ectopic pregnancy, which can be emotionally devastating for the parents.

It is important to monitor pregnancy closely and seek medical attention promptly if any concerning symptoms arise. With proper care and management, many pregnancy complications can be treated effectively, reducing the risk of harm to both the mother and the baby.

Treatment failure is a term used in medicine to describe the situation when a prescribed treatment or intervention is not achieving the desired therapeutic goals or objectives. This may occur due to various reasons, such as:

1. Development of drug resistance by the pathogen or disease being treated.
2. Inadequate dosage or frequency of the medication.
3. Poor adherence or compliance to the treatment regimen by the patient.
4. The presence of underlying conditions or comorbidities that may affect the efficacy of the treatment.
5. The severity or progression of the disease despite appropriate treatment.

When treatment failure occurs, healthcare providers may need to reassess the patient's condition and modify the treatment plan accordingly, which may include adjusting the dosage, changing the medication, adding new medications, or considering alternative treatments.

In a survey of the North American embryo transfer industry, embryo transfer success rates from direct transfer of embryos were ... How embryo transfer works as part of fertility treatment The blastocyst transfer process - a form of embryo transfer One at a ... Factors that can affect the success of embryo transfer include the endometrial receptivity, embryo quality, and embryo transfer ... for embryo expulsion • Immediate ambulation once the embryo transfer procedure is completed Embryo transfer techniques allow ...
"Agriculture for Impact Embryo Transfer". Archived from the original on 2020-07-31. Retrieved 2020-04-15. Fletcher, Amy Lynn ( ... "Ectoderm , The Embryo Project Encyclopedia". embryo.asu.edu. Retrieved 2019-11-07. "Mesoderm , The Embryo Project Encyclopedia ... Jones, DG; Telfer, B (January 1995). "Before I was an embryo, I was a pre-embryo: or was I?". Bioethics. 9 (1): 32-49. doi: ... The structure and development of the rest of the embryo varies by group of plants. Since all land plants create embryos, they ...
... conferring different stages of embryogenesis at embryo transfer. The main stages at which embryo transfer is performed are ... Monozygotic twinning is not increased after blastocyst transfer compared with cleavage-stage embryo transfer. There are ... Embryo culture until the blastocyst stage confers a significant increase in live birth rate per embryo transfer, and there is ... "Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer". ...
Direct Frozen Embryo Transfer: Embryos can be frozen by SPF in ethylene glycol freeze media and transfer directly to recipients ... pregnancy following the transfer of a 8-cell frozen-thawed embryo into human subjects transferring 8-cell cryopreserved embryos ... and embryos may be created, frozen and stored specifically for transfer and donation by using donor eggs and sperm. Embryo ... and number of transferred embryos are predictors of pregnancy outcome. Pregnancies have been reported from embryos stored for ...
Embryo transfer: the strongest and genetically correct embryos are selected and the decided number will be transferred to the ... A fresh embryo transfer IVF cycle lasts around 17-20 days and 10 days after the embryo is transferred to wait for the results ... A frozen embryo transfer first involves one of the cycles dedicated to the genetic mother. The second cycle is dedicated to the ... The actual timing for a frozen embryo transfer is longer and depends on the entire time it takes for two menstrual cycles of ...
AI software designed to assist embryologists and clinicians during the embryo selection process leading to embryo transfer, a ... Embryo selection In vitro fertilisation and embryo selection "P-413 - DEEP LEARNING FOR AUTOMATIC DETERMINATION OF BLASTOCYST ... "Predicting pregnancy test results after embryo transfer by image feature extraction and analysis using machine learning". ... Following feature extraction, ERICA accurately ranks embryos according to their prognosis (defined as euploidy and implantation ...
Frozen embryo transfer; IVF using ovarian hyperstimulation, followed by embryo cryopreservation, followed by embryo transfer in ... As only one embryo is transferred in a natural cycle, there is virtually no risk of a multiple pregnancy. Furthermore, ovarian ... "Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence". Human Reproduction ... thus increasing their chance of producing an embryo that will result in a live birth. However, as this protocol to use more and ...
"Embryo Transfer Enrollment". AQHA. 2018-04-10. Retrieved 2019-10-12. (Articles with short description, Short description is ... for limiting the number of foals that could be registered per year per mare from embryo transfers, which was one foal at that ... both of which resulted from multiple embryo transfers from the same mare in the same year. The lawsuit caused a stir among ... breeders who were in disagreement over multiple registrations resulting from multiple embryo transfers but Floyd was not asking ...
Frozen embryo transfer; IVF using ovarian hyperstimulation, followed by embryo cryopreservation, followed by embryo transfer in ... as it is not uncommon for multiple embryos to implant if multiple embryos are transferred. Embryos are transferred to the ... This is directly related to the practice of transferring multiple embryos at embryo transfer. Multiple births are related to ... Before the transfer of a pre-embryo back to a woman's uterus, one or two cells are removed from the pre-embryos (8-cell stage ...
... a method adapted from the commercialization of bovine embryo transfer in the cattle industry - as a means to transfer human ... "Embryo-Transfer Baby Born". The New York Times. 1984-03-25. Retrieved 27 June 2014. "Previvo Genetics - A New Choice in Pre- ... In the procedure, an embryo that was just beginning to develop was transferred from the woman in whom it had been conceived by ... Building upon Buster's research, over 200,000 live births resulting from donor embryo transfer have been recorded by the ...
Average success rates in Embryo Transfer in terms of embryos recovered can vary widely. Each breed will respond differently to ... Embryo transfer procedures are used to allow producers to maximize those females that produce the best lambs/kids either for ... During embryo transfer (ET) a minor surgical procedure with almost no risk of injury or infection when performed properly, ... "American Embryo Transfer Association". Retrieved 19 October 2014. Coleby, Pat (2000). Healthy sheep : naturally. Victoria: ...
"Regulatory Subcommittee". International Embryo Transfer Society. Retrieved 1 November 2014. "Home Page". Association of Zoos & ... O'Brien is co-chair of the Regulatory Subcommittee of the International Embryo Transfer Society's Parent Committee on Companion ...
... embryo transfer, and cloning, respectively. Hybridization with domestic cattle has been successfully achieved by ICR, in order ... Cryopreservation of embryos is dependent on the species and the stage of development of the embryo. Pig embryos are the most ... "The Embryo Project Encyclopedia." The First Successful Cloning of a Gaur (2000), by Advanced Cell Technology. The Embryo ... Vitrification is the preferred method of embryo freezing because it yields higher quality embryos. It is crucial technicians ...
Once all parties agree, the embryo is transferred to the adoptive mother's clinic for a frozen embryo transfer.[citation needed ... Preborn Babies National Registry for Adoption National Embryo Donation Center Embryo Adoption & Embryo Donation Academy Embryo ... "embryo adoption" is a misnomer because the transfer of an embryo is handled as property transfer. One newspaper article in 2005 ... Recipients of embryos donated for procreative implantation typically plan to transfer fresh or frozen embryos into a prepared ...
Embryo transfer is more widespread. A male is usually ready to mate for the first time between two and three years of age. It ...
In Jainism, the birth of Mahavira is depicted as an operation of embryo transfer. In modern-day India, there have been clones ... "Historical Note on Embryo Transfer". Fertility and Sterility. 34 (5): 513-515. doi:10.1016/s0015-0282(16)45148-4. PMID 7002632 ... Religious groups are divided, with some opposing the technology as usurping God's place and, to the extent embryo are used, ... Watanabe S (September 2013). "Effect of calf death loss on cloned cattle herd derived from somatic cell nuclear transfer: ...
Nelson, Harry (1984-02-04). "Woman Bears Son by Embryo Transfer". Retrieved 2010-11-02. (BLP articles lacking sources from ... Marshall, along with John Buster, was one of the developers of the technique that resulted in the first successful transfer of ... John R. Marshall, M.D., helped orchestrate the world's first embryonic transfer. Marshall attended Pomona College and received ...
Trounson, Alan O.; Wood, Carl (1984). In Vitro Fertilization and Embryo Transfer. ISBN 978-0-443-02675-1. Trounson, Alan; Wood ... In Vitro Fertilization and Embryo Transfer. ISBN 978-0-443-02675-1. Sathananthan, A. Henry; Trounson, Alan O.; Wood, Carl ( ... ISBN 978-0-521-79958-4. Verma, Paul J.; Trounson, Alan O. (2006). Nuclear Transfer Protocols: Cell Reprogramming and ... They were the use of a fertility drug to induce multiple ova and the freezing of embryos for future use. These procedures ...
Centenary of his embryo transfer experiments". Reproduction. 93 (1): 173-186. doi:10.1530/jrf.0.0930173. ISSN 0022-4251. PMID ... In 1891, Heape reported the first successful embryo transfer in a mammal.[better source needed] As early as 1934, Gregory ... The ability to freeze and subsequently thaw and transfer embryos has significantly improved the feasibility of IVF use. In 1983 ... Blakeslee, Sandra (1984-02-04). "INFERTILE WOMAN HAS BABY THROUGH EMBRYO TRANSFER". The New York Times. ISSN 0362-4331. ...
K. J. Betteridge (1981). "An historical look at embryo transfer". Reproduction. 62 (1): 1-13. doi:10.1530/jrf.0.0620001. PMID ... The form of any given embryo does not converge upon other definite forms, but separates itself from them. The embryo of a ... von Baer formulated what became known as Baer's laws of embryology: General characteristics of the group to which an embryo ... higher animal form never resembles the adult of another animal form, such as one less evolved, but only its embryo. Baer was a ...
Lee also wrote an article in the Sunday Times (10 November 2002) in the aftermath of a number of high-profile embryo transfer ... "Immunosuppressive activity in human IVF culture supernatants and prediction of outcome of embryo transfer". Journal of in Vitro ... Lee also had a keen interest in ethics and expressed this at UCL by running a course titled "Ethics of Fertility and Embryo ... Fertililisation Embryo Transfer. 6 (1): 51-58. doi:10.1007/BF01134582. PMID 2651541. S2CID 9400038. S. Lee; H Rivas-Toro (2001 ...
Daniel Q. Haney (November 21, 1985). "Says embryo transfer could help childless couples". The Lewiston Journal. p. 16. ...
Embryo transfer programme is also carried out in 15 districts from this embryo transfer unit. In the next project, indigenous ... Embryos from Red Sindhi cows are collected by multiple ovulation and embryo transfer technology and are transferred to cross- ... Apart from these projects, pure Jersey and HF embryos have been imported and transferred to the recipient cows at the ... Twenty imported frozen pure Jersey embryos were transferred to crossbred cows and ten became pregnant. Agriculture and Agronomy ...
The resulting embryo or embryos are then transferred into the intended mother instead of into the woman who provided the egg. ... Remaining embryos are frozen, whether for future transfers if the first one fails, for siblings, or for eventual embryo ... whose uterine lining has been appropriately prepared for embryo transfer beforehand. If a large number of viable embryos are ... is embryo donation. Embryo donation is the use of embryos remaining after a couple's IVF treatments have been completed, to ...
In 1906 Heape was elected F.R.S. By focusing on Heape's embryo transfer experiments we should not conclude that this work was ... Centenary of his embryo transfer experiments" (PDF). J. Reprod. Fertil. 93 (1): 173-186. doi:10.1530/jrf.0.0930173. PMID ... Betteridge, Keith J. "An historical look at embryo transfer." Journal of Reproduction and Fertility 62.1 (1981): 1-13 doi: ... In November 1897 he published a second paper on his embryo transfer experiments. ...
Use in combination with assisted reproductive technology such as embryo transfer is also not recommended. For people with back ... Küçük, M (April 2013). "Bed rest after embryo transfer: Is it harmful?". European Journal of Obstetrics, Gynecology, and ...
Embryo transfer protocol was established at the Central Cattle Breeding and Dairy Farm. The government of Bangladesh plans to ... "Artificial insemination and implementation of embryo transfer technology". The Asian Age. Retrieved 25 December 2020. "সাভার ...
1984). "In vitro fertilization in Norfolk, Virginia, 1980-1983". Journal of in Vitro Fertilization and Embryo Transfer. 1 (1): ...
Law and ethics of AID and embryo transfer. Ciba Foundation symposium. Vol. 17. London: Associated Scientific. pp. 63-66. OCLC ...
Journal of In Vitro Fertilization and Embryo Transfer. 3 (2): 114-117. doi:10.1007/BF01139357. PMID 3701181. S2CID 27421288. ... "Outcome in 242 in vitro fertilization-embryo replacement or gamete intrafallopian transfer-induced pregnancies". Fertility and ... Artificial induction of ovulation and in vitro fertilization-embryo replacement can also give rise to fraternal and identical ...
In a survey of the North American embryo transfer industry, embryo transfer success rates from direct transfer of embryos were ... How embryo transfer works as part of fertility treatment The blastocyst transfer process - a form of embryo transfer One at a ... Factors that can affect the success of embryo transfer include the endometrial receptivity, embryo quality, and embryo transfer ... for embryo expulsion • Immediate ambulation once the embryo transfer procedure is completed Embryo transfer techniques allow ...
A new study found that rates of adverse events with embryo transfer catheters ‫― including contamination and patient harm ― may ... "In two of these reports, they failed to transfer the embryo; they actually lost the embryo," Pomeroy added. "Thats drastic for ... Adverse events related to the use of embryo transfer catheters (ETCs) may be underreported to the US Food and Drug ... Cite this: Adverse Events Related to Embryo Transfer Catheters May Be Underreported to the FDA - Medscape - Oct 25, 2023. ...
What is elective single embryo transfer (eSET)?. Elective single-embryo transfer (eSET) is a procedure in which one embryo, ... embryo transferred had a similar number of live-birth deliveries compared to those who chose to transfer multiple embryos, but ... cryopreserved embryos (frozen)) or from the current fresh IVF cycle that yielded more than one embryo. The remaining embryos ... The complete guidelines on number of embryos transferred in ART cycles can be found on SART Web site. ...
This book briefly reviews the history of equine embryo transfer, covering in clinically practical terms the techniques, ... Embryo micromanipulation (splitting). Embryo sexing. 20. Future directions of equine embryo transfer. Superovulation. Early ... Cryopreservation of Embryos. History of embryo freezing. Slow freeze vs Vitrification. Selection of embryos (flush days, embryo ... x Embryo Transfer Pregnancy Rate (70-80%). Goals of the Manual. 2. History of equine embryo transfer Livestock. Horses. ...
Concerns have been raised over the past few years that pregnancies derived from frozen embryo transfers in IVF might increase ... facilitation of single embryo transfer, reduction of ovarian hyperstimulation, and the elective freezing of all embryos ( ... duration of embryo culture or number of embryos transferred). ... Pregnancies following frozen embryo transfer have higher risk ... He added: In our analysis all natural conceptions and fresh embryo transfer pregnancies had a corpus luteum, while a subset of ...
Malpani Infertility Clinic is one of the best IVF Clinic in India for Infertility Treatment. This ivf clinic in mumbai has highest pregnancy rate.
The transfer catheter has an internal support cannula. , Guardia™ Access Nano Embryo Transfer Catheter ... embryos into the uterine cavity. The outer diameter of the guide catheters bulb tip is reduced for smaller anatomy. ... Guardia Access Nano Embryo Transfer Catheter. Guardia Access Nano Embryo Transfer Catheter. ... Used to place in vitro fertilized (IVF) embryos into the uterine cavity. ...
Now you are super excited to get to the fun part, right? The day of your long awaited frozen embryo transfer (FET)! However, ... Some REs may even allow you to complete a natural cycle transfer with no birth control or medications. Talk with your clinic to ... You have decided you want to pursue embryo adoption and have completed all the necessary steps. You have chosen an agency, ... Snowflakes Embryo AdoptionInternational AdoptionDomestic AdoptionAdoption from Foster CareFoster Care ...
Is Frozen Embryo Transfer Best?. by carolinaconceptions , Jun 28, 2017. Frozen Embryo Transfers Increase Pregnancy Rates in ... Embryos are cultured for 5 to 6 days in vitro. The highest quality embryo will be selected and transferred into the uterus on ... How Many Embryos Should I Transfer?. by carolinaconceptions , Apr 6, 2017. By: Dr. Meaghan Bowling One of the critical ... Embryo transfer. Behind the Scenes with Dr. Meyer. by carolinaconceptions , Sep 6, 2017 ...
Vigro Embryo Holding Media [h] was used to rinse and hold the embryos before transfer. Embryos were held at room temperature ... A 50% embryo-recovery rate per ovulation and a 50 - 65% pregnancy rate per transferred embryo is expected in commercial embryo- ... in embryo-transfer protocols. The coasting period has been shown to be beneficial in some bovine embryo-transfer protocols. ... 1 pregnancies per transferred embryo, eFSH mean = 0.2 ± 0.4 pregnancies per transferred embryo, eFSH range = 0 - 1 pregnancies ...
Revisions to Guidelines for Embryo Transfers. Revisions to Guidelines for Embryo Transfers. PFC has been a pioneer in enabling ... euploid embryos, first frozen embryo transfer (FET) cycle, or previous live birth after an IVF cycle. The numbers to transfer ... If euploid embryos are available, a single-blastocyst embryo transfer should be the standard practice, and is our practice at ... through the use of genetic testing and freezing of embryos for later use. At PFC we elect to transfer one embryo in over 90% of ...
How many embryos should you transfer? Ideally it is best to transfer only one embryo at a time. Pregnancy rates are higher […] ... Watch Our Single Embryo Transfer Video featuring IRMS Dr. Debbra Keegan and Dr. Serena Chen ... When More Is Not Better - Why You Should Transfer One Embryo At A Time ... IRMS NJ Discusses: What Is Up With These MOSAIC EMBRYOS? What You Need To Know ...
RN with Shady Grove Fertility shares quick facts about having a frozen embryo transfer, or FET. ... SGF performs about thousands of frozen embryo transfers each year with comparable success rates to fresh IVF cycles.. Tags: * ... Elizabeth Zapp, RN with Shady Grove Fertility shares quick facts about having a frozen embryo transfer, or FET. In recent years ... Frozen Embryo Transfers (FET) Explained. *6 Things to Know About Frozen Embryo Transfers ...
My Frozen Embryo Transfer was cancelled due to Covid-19. Read more about my story and struggles with infetility gearing up for ... Failed Frozen Embryo Transfer #3 - Failed IVF - eat.sleep.wear - […] Covid-19 Cancelled My Embryo Transfer […]ReplyCancel ... STARTING MY FROZEN EMBRYO TRANSFER CYCLE. We decided to prep for a transfer at the end of March so that meant starting our ... We have 3 frozen embryos that have been genetically tested and our plan moving forward was to do a FET (frozen embryo transfer) ...
... by Samiha Khanna, Duke University Medical Center ... IVF experts disagree about whether transferring a fresh or frozen embryo to a patients womb offers the best opportunity for ... Some research has also indicated frozen embryo transfers are less likely to result in preterm labor and underweight babies, he ... No benefit in IVF from routinely freezing all embryos before transfer. Jun 17, 2015 ...
... embryo for transfer: novel insights from advanced genetic analysis of bovine and equine embryos How to select the embryo for ... How to select the embryo for transfer: novel insights from advanced genetic analysis of bovine and equine embryos ... allowing for production of more embryos that can be transferred to the uterus and additionally, be selected or ranked upfront ... transfer: novel insights from advanced genetic analysis of bovine and equine embryos. Promovendus/a. De Coster, Tine Faculteit ...
... one of which is gamete intra-fallopian transfer (GIFT). The first example of GIFT involved primates during the 1970s; however, ... embryo or embryos will divide normally, move down to the uterus to implant, and result in a healthy live birth. ... no decisions are made as to which embryos are implanted or discarded, the embryo itself is not manipulated, and fertilization ... The transfer of multiple oocyctes carries the possibility of multiple pregnancies, which occurs in an estimated thirty percent ...
Extra embryos are stored for future use. One at a time, transferring a healthy single embryo after IVF maintains high pregnancy ... With CCS, the average number of embryos transferred declined, yet the pregnancy rate pre transfer was significantly higher. ... A single embryo can be transferred, while maintaining excellent pregnancy rates. Dr. Chenette is director of PFC s Fertility ... PFC Staff to Present Abstract on Single Embryo Transfer (SET) at ASRMs 2014 Annual Meeting. PFC Staff to Present Abstract on ...
Maternal spindle transfer is a feasible approach to enhance embryonic developmental of compromised oocytes, which can represent ... Maternal spindle transfer (MST) between sibling fresh B6CBAF1 mouse oocytes does not impair embryo development.. (a) Schematic ... a-c) Second polar body biopsy of a 2 cell stage MST embryo. (d-f) Blastomere biopsy of a 8 cell stage MST embryo. (g-i) ... Maternal spindle transfer overcomes embryo developmental arrest caused by ooplasmic defects in mice. ...
... and donor egg treatment may wonder how many embryos to transfer, our expert physicians are here to answer and inform. ... Learn more about SGFs single embryo transfer success rate. SGF financial programs support single embryo transfers It has been ... What is elective single embryo transfer (eSET)? eSET is elective single embryo transfer, a process by which one good quality ... Blastocyst embryos have a much higher chance of implanting than other embryos, therefore fewer embryos are required to achieve ...
Protocols for Obtaining Zygotic and Somatic Embryos for Studying the Regulation of Early Embryo Development in the Model Legume ...
Our Austin fertility center explains what to know about embryo mosaicism. ... Should you transfer a mosaic embryo?. An embryo that has a mosaic PGT-A result may have the potential to develop into either a ... Learn more about the guidelines for transferring mosaic embryos. If you learn that some of your embryos have mosaicism, you ... In certain cases, we do not recommend transferring mosaic embryos. As such, it should be a last resort. Embryos with mosaic ...
First of all, congratulations! The embryo transfer is a huge milestone in your fertility journey, and you can be proud of ... Here are some simple tips weve learned over our decades of experience transferring embryos to help you focus on this exciting ... and youre looking for post-embryo transfer tips to improve chances of a successful implantation. ... Post-Embryo Transfer Tip #1: Remember, the Embryo Cant Fall Out. Once the embryo has been transferred, it cant "fall out" of ...
The embryo transfer is the final step in a long journey toward building your family. Preparing for this day and knowing what to ... Preparing for Your Embryo Transfer. The best way to prepare for your embryo transfer is to follow all directions from your ... Whether you are doing a fresh embryo transfer or a frozen embryo transfer, youll likely be on progesterone and other ... 1) The embryo cannot fall out! Patients often prefer to relax a few minutes after the embryo transfer, but studies do show that ...
... a 5-6 day old Embryo Transfer) can result in higher implantation rates compared to 3-day old Embryo Transfer Procedures. Learn ... results in higher implantation rates per embryo transferred compared to a day three embryo transfer. An embryo reaching the ... Growing embryos to blastocyst stage:. Traditionally, in an IVF cycle, embryos were transferred to the uterus on the second or ... Blastocyst (Day 5 or 6) Embryo Transfer. What is a Blastocyst?. A blastocyst is an embryo that has developed in culture in the ...
Todays day 2 of my embryo transfer and I got really upset and angry at my DH. Was yelling, stressed, kicked a shelf, just ... 2 days post embryo transfer is still too early for the embryo to have attached, so this symptom can only be due to the effect ... Todays day 2 of my embryo transfer and I got really upset and angry at my DH. Was yelling, stressed, kicked a shelf, just ... 2 weeks post IVF 5-day, 2 blastocyst embryo transfer and beta results ...
AN EGG-TRANSFER STUDY OF EMBRYO SURVIVAL AND MATERNAL PERFORMANCE IN FINN, GALWAY ANE FINGALWAY SHEEP. J. P. HANRAHAN and J. F ...
The technology used in freezing embryos significantly increases the likelihood of pregnancy per IVF cycle. ... the embryo is thawed for frozen embryo transfer.. Why consider freezing embryos?. If fresh embryo transfers are not working, ... Frozen Embryo Transfer (FET) Embryo transfer is the final step of the IVF process, where the embryos which were fertilized in ... fresh embryo transfer?. Pregnancy success rates in patients receiving thawed embryo transfers at SCRC are consistently close to ...
... when pronuclear and two-cell embryos were transferred to females in estrus that were stimulated on the day of embryo transfer. ... which were transferred to females with pseudopregnancy induced on the day of embryo transfer. This study demonstrated that ... Offspring were obtained from two-cell embryos transferred into females with pseudopregnancy induced using sonic vibration in ... proestrus on the day before embryo transfer. Furthermore, high developmental rates of offspring were observed ...
... (eSET). Last updated: November 10, 2023 What Does Elective Single Embryo Transfer (eSET) Mean? ... Elective single embryo transfer (eSET) is the selection and transfer of a single embryo during an IVF Cycle. Because a single ... The single embryo can be a frozen (cryopreserved) embryo elected from an earlier IVF cycle or it can be a fresh embryo chosen ... FertilitySmarts Explains Elective Single Embryo Transfer (eSET). To perform an eSET and choose the best-quality embryo, the ...

No FAQ available that match "embryo transfer"

No images available that match "embryo transfer"